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Resumo 
 
 
 
O sono é um processo natural, no qual ocorre uma perda gradual da consciência do ambiente 
externo e um aumento do relaxamento dos músculos. Devido ao papel fundamental que o sono 
tem no sistema imunitário e no sistema nervoso e devido ao aumento dos distúrbios do sono ao 
longo dos anos, a monitorização da qualidade do sono é de extrema importância. A polissono-
grafia é o exame standard para a monitorização do sono e para a deteção de distúrbios de sono, 
no entanto tem algumas desvantagens, como o facto de ser economicamente dispendioso, não 
estar disponível em todos os hospitais/clínicas de sono e o facto de ser incómodo para o paci-
ente. Com a evolução dos dispositivos vestíveis, estes surgem como uma possível solução para 
monitorizar o sono fora do ambiente hospitalar, de forma não invasiva, e fornecendo continu-
amente informações de variáveis fisiológicas.   
O objetivo desta Tese de Mestrado é desenvolver um novo sistema vestível para monitorizar 
o sono, denominado VitalSleep. O sistema VitalSleep consiste no desenvolvimento do hardware, 
na aquisição do registo do sono em tempo real e no desenvolvimento da unidade de processa-
mento do estadiamento do sono que consiste no pré-processamento dos sinais e no desenho e 
na validação do algoritmo para o estadiamento do sono. Este dispositivo será uma extensão da 
tecnologia VitalJacket®, um produto da Biodevices, S.A. O VitalJacket®, dispositivo médico 
vestível certificado, é uma t-shirt com sensores incorporados, capaz de monitorizar o sinal de 
eletrocardiograma, temperatura e dados de acelerómetro, de forma contínua.  
O sistema VitalSleep será então capaz de monitorizar a saturação de oxigénio, os movimen-
tos dos olhos, a temperatura, os movimentos corporais e o eletrocardiograma. Antes do desen-
volvimento deste sistema foi realizado um estudo sobre o sono e as respetivas variáveis moni-
torizadas. De seguida, foi necessário perceber a arquitetura genérica de um dispositivo vestível 
e fazer um estudo aprofundado sobre o tipo de dispositivos vestíveis que existem no mercado 
para monitorizar o sono, bem como os sensores usados. Por fim, foi feito um estudo sobre as 
tendências do mercado, de forma a perceber qual seria o melhor investimento num novo dis-
positivo para monitorizar o sono de forma ambulatória.  
Para o desenvolvimento do sistema VitalSleep foi necessário a criação e implementação de 
uma placa de circuito impresso (PCB) que estende a tecnologia da Biodevices. S.A, que consiste 
no desenho e produção do PCB usando o software de desenho de circuitos impressos, Altium, 
e a sua respetiva montagem. De seguida, foi desenvolvido o firmware usando o IDE software 
(MPLAB), baseado na linguagem C, necessário para incorporar os sensores implementados no 
microcontrolador. Finalmente, foi feita uma análise dos respetivos sinais utilizando o MATLAB 
vi 
 
e a obtenção de um gráfico representativo do estadiamento do sono com base nas variáveis 
fisiológicas monitorizadas.  
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Abstract 
 
 
 
Sleep is a natural process characterized by a gradual loss of consciousness of the external 
environment and by an increase relaxation of the muscles. Due to the fundamental role that 
sleep plays in the immune and nervous system and due to the increase of sleep disorders over 
the years, the sleep monitoring is extremely important. Polysomnography is the standard exam 
for sleep monitoring and for the detection of sleep disorders, but it has some disadvantages, 
such as being expensive, not available in all hospitals/clinics, and is uncomfortable for the 
patient. With the evolution of wearable devices, these appear as a possible solution to sleep 
monitoring out of medical environment, providing, continuously and in a non-invasively way, 
information of physiological variables. 
The objective of this Master Thesis is to develop a wearable system capable of sleep mon-
itoring, named VitalSleep. VitalSleep system consist in the development of the hardware, in 
the acquisition of the sleep recording in real-time and in the development of the sleep stage 
processing unit that consists in the pre-processing of the signals and design and evaluation of 
an algorithm to analyse the sleep stages. This device will be an extension of VitalJacket® 
Tecnhology, a product of Biodevices, S.A. VitalJacket®. VitalJacket® was the first certified 
wearable medical device, T-shirt, with built-in sensors, capable of monitoring, continuously, 
the electrocardiogram signal, temperature and accelerometer data. 
The VitalSleep system will be able to monitor oxygen saturation, eye movements, temper-
ature, body movements, and electrocardiogram signal. Before the development of this proto-
type, a state-of-the-art research was performed on sleep and its monitored variables. Then an 
in-depth study was performed on the generic architecture of a wearable device, the type of 
wearable devices that exist in the market to monitor sleep as well as the sensors used. Finally, 
market trends were analysed in order to understand the best investment in a new system to 
ambulatory monitoring of sleep.  
For the development of VitalSleep system it was first necessary to design and implement 
a printed circuit board (PCB) that extends Biodevices, S.A. technology, consisting in the design 
and production of the PCB using the printed circuit design software, Altium, and the assembly 
of the PCB. Then the firmware needed to incorporate the sensors in the microcontroller was 
developed using the IDE software (MPLAB), which is based on C language. Finally, signal anal-
ysis was performed using MATLAB and the obtaining of a representative graph of sleep staging 
based on the physiological variables monitored. 
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Chapter 1 
 
 
Introduction 
 
 
 
Sleep has a strong influence on nervous and immune functions. Although it is extremely 
important to sleep well, many people suffer from sleep disorders and underestimate it. In many 
cases, these disorders are not diagnosed and/or treated. Polysomnography is the standard exam 
for sleep monitoring and for the detection of sleep disorders. However, because it is very inva-
sive, expensive and unavailable in all sleep hospitals / clinics, wearable devices appear as a 
possible solution to monitor sleep [1], [2].  
The purpose of this Master Thesis was to develop a system of a new wearable device capable 
of monitor sleep, named VitalSleep. The VitalSleep system is an extension of VitalJacket®. This 
Master Thesis was developed in the Faculty of Engineering of the University of Porto and in 
INESC TEC Porto with the collaboration of Biodevices, S.A., and supervised by Professor Ph.D. 
João Paulo Cunha.  
 
This Master Thesis is divided in 6 chapters. Chapter 1 presents a brief introduction of what 
was developed during this work, the motivation to have chosen this theme, as well as the 
outline of the aims for the elaboration of this dissertation. The Chapter 2 approaches an in-
depth study of sleep, polysomnography - the standard sleep monitoring exam - and variables 
monitored in this exam. A study of commercial wearable devices and prototypes that already 
exist to monitor sleep and a study of the market trends regarding wearable devices are pre-
sented in Chapter 3. Chapter 4 describes the development of the VitalSleep system including: 
design and implementation of the PCB, implementation of the firmware, the signal analysis of 
the variables monitored, the design of the algorithm to sleep staging and the evaluation of this 
algorithm using the PhysioNet Database. This database has a large archive of physiological data, 
including files with sleep stages annotations.  Finally, Chapter 5 approaches the conclusions of 
this Master Thesis and future work suggestions.  
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1.1. Background and Context 
 
Sleep is essential for a mental and physical recovery of the body; however, sleep disorders 
have been increasing and the sleep quality of the population has been decreasing over the 
years. Poor sleep quality affects not only the person's day-to-day, but also, may increases the 
risk of, for example, cardiovascular disease. It is therefore extremely important to continuously 
monitor sleep [1], [2]. 
 
Wearable devices can continuously monitor physiological parameters and allow to save 
and/or send this data in real time through wireless protocols or mobile communications. These 
devices can be a solution for the prevention of diseases caused by poor quality of sleep and can 
be a warning to improve the quality of life. There are already commercial devices for sleep 
monitoring, but they are mostly based on actigraphy such as watches and bracelets, which end 
up being uncomfortable during sleep and some of them are unfeasible [3], [4]. 
 
VitalJacket® from Biodevices, S.A. was the first certified smart medical device t-shirt, 
which allows to acquire and save the data of the electrocardiogram signal, and also to send this 
data in real time, via Bluetooth, to a mobile device [5]. Although this device has not been 
designed for sleep monitoring, its expansion to this area of the market is possible due to its 
versatile architecture that possibility the incorporation of more sensors. 
 
This Master Thesis presents the development of a system of a new wearable device, called 
VitalSleep, capable of continuously monitoring sleep, through electrooculogram, oxygen satu-
ration, electrocardiogram, temperature and actigraphy. These last three parameters already 
implemented in the VitalJacket®. Since VitalSleep system is a wearable device to be used at 
night, one of the criteria is to be small and comfortable, to not influence the results. 
 
1.2. Motivation 
 
Sleep quality improves mental well-being and allows the body to regenerate and recover. 
However, the number of people who suffer from sleep disorders is growing [1], [2]. 
 
Wearable devices have evolved over the years and have been increasingly used for contin-
uous monitoring of physiological variables. Since the standard exam of sleep monitoring, poly-
somnography, is very expensive, is not available in all sleep hospitals / clinics, and is inconven-
ient for the patient, wearable devices have been used for ambulatory monitoring [4]. 
 
The conjunction of the area of electronics with the area of human physiology is fascinating 
to me, so the development of this Master Thesis theme has captured all my interest. In addition, 
the possibility of developing a prototype of a wearable device that could be an extension of 
the main board of the VitalJacket®, product of Biodevices, S.A., seemed extremely enriching. 
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1.3. Objectives 
 
The goal of this Master Thesis is to develop a system able to sleep monitoring, named Vi-
talSleep. VitalSleep system consist in the development of the hardware, in the acquisition of 
the sleep recording in real-time and in the development of the sleep stage processing unit that 
consists in the pre-processing of the signals and design and implementation of an algorithm to 
analyse the sleep stages. For this development it is necessary to do, initially, a study about the 
sleep - which variables are monitored during the polysomnography and what information they 
provide. Then is necessary to understand the generic architecture of a wearable device and to 
do a study of different types of wearable devices that already exist in the market to monitor 
sleep. Finally, it is necessary to study the market trend regarding wearable devices, to better 
define the prototype characteristics.  
 
After performing these studies, it is necessary to design and implement the PCB using the 
software Altium, and assembly the PCB. Then the firmware IDE software (MPLAB) is developed 
to incorporate the implemented sensors in the microcontroller. The analysis of the signals in 
MATLAB is the following step. Finally, it is necessary to design an algorithm to sleep staging 
and to evaluate this algorithm using the PhysioNet Database, a database that has a large archive 
of physiological data, including files with sleep stages annotations. 
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Chapter 2 
 
 
Sleep Characteristics and Physiological 
Variables Monitored 
 
 
 
Sleep is defined as the recording of electrical activity of cortical neurons and muscle cells 
[6] and has a strong influence on nervous and immune functions [1].   
More than 30 million people suffer from sleep disorders [1]. As a consequence, the mental 
condition decreases and the risk of cardiovascular diseases increases [2]. Therefore, it is nec-
essary to monitor the quality of sleep to diagnose possible disorders and to do treatments or 
improvements in the quality of life. 
Polysomnography (PSG) is the standard exam for sleep monitoring, however, it is expensive, 
requires specialists and is not available at all hospitals/sleep clinics. Wearable devices, alt-
hough still recent and not yet mostly in the medical field, appear as a possible alternative to 
PSG, since they are inexpensive, do not require specialist, and the patient can perform moni-
toring in the comfort of their home [7],[2].  
 
This chapter begins with a description of different stages of sleep. Then, it approaches 
various types of sleep disorders with more emphasis on obstructive sleep apnea (OSA) because 
it is very common in the population, as well as the advantages, disadvantages and the param-
eters monitored in the PSG standard exam.  
    
 
2.1. Sleep Stages 
 
During a normal period of nocturnal sleep of an adult – 6 to 8 hours -, occur 4 to 6 sleep 
cycles. Each cycle has a duration of about 90 minutes and contains different stages: REM (rapid 
eye movement) sleep and NREM (non rapid eye movement) sleep that is subdivided into 4 
phases: stages I and II are known as light sleep and stages III and IV are known as deep sleep or 
slow wave sleep (SWS). It is noteworthy that American Academy of Sleep Medicine (AASM) [8] 
joined phases III and IV in a single phase N3. In a sleep cycle can also occurs awakenings with a 
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duration of about 15 seconds and excitations with a duration between 1.5 and 3 seconds [2], 
[6]. 
NREM sleep is mainly characterized by parasympathetic and cognitive activity and the REM 
sleep is characterized by sympathetic activity and emotional dreams [6], [9]. In NREM sleep 
occurs a decrease of several physiological parameters, namely, heart rate, blood pressure and 
muscle tone, the movements of the eyes are slow or inexistent and the cerebral activity is 
reduced. [9] The N1 phase is characterized by a gradual loss of consciousness of the external 
environment, slow eye movements, a reduction of muscle tone and the appearance of theta 
waves that replace alpha waves. Theta and alpha waves may also appear alternately. The N2 
phase is characterized by total loss of consciousness, predominance of the activity of waves 
with moderate amplitude, appearance of K-complexes1 followed by bursts of spindles2 and the 
disappearance of slow eye movement. The N3 phase is characterized by the appearance of slow 
waves of high amplitude, delta waves, and the reduction of muscle tone [10], [11]. During REM 
sleep the values of heart rate, respiratory rate and blood pressure are variable, occurs rapid 
eye movements, brain activity is high, and occurs a complete loss of muscle tone [10], [11]. 
Thus, the information provided by the EEG, EOG and EMG allows to classify the different stages 
of sleep [11]. The Figure 2.1.1 represents the main characteristics of these signals associated 
to each phase [10]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1 K-complexes - events with a negative wave of large amplitude followed by a slow positive 
wave [10] 
2 Spindles - transient episodes with frequency between 12 and 14 Hz [10] 
 
Figure 2.1.1 - Characterization of each phase of sleep: stage W (wake), stage NREM (stage 1, 
stage 2, stage 3 and stage 4) and stage REM according to the information provided by the EEG, 
EOG and EMG (taken from [10]) 
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In a normal night’s sleep, – Figure 2.1.2 - the N1 phase occurs in the first moment of sleep, 
then the sleep becomes deeper, passing through phase N2 to phase N3. The first episode of 
deep sleep is long - between 20 to 60 minutes. Then, sleep progresses to a lighter sleep state 
(phases N2 and N1) and may occurs a transient wakefulness period before the first REM sleep.  
The first REM sleep appears about 90 minutes after the onset and lasts between 1 and 5 minutes. 
Thus, ends the first cycle of sleep. It should be noted that the REM phase increase throughout 
the night, contrary to the deep sleep. In addition, the periods of vigilance of short duration are 
very frequent at the end of the night [9]. It is also important to refer that 75% to 90% of total 
sleep time is NREM sleep: 3% to 5% corresponds to the N1 phase, 50% to 60% corresponds to the 
N2 phase and 10% to 20% corresponds to the phase N3. The REM sleep represents 10% to 25% of 
total sleep time [2], [6], [12]. 
 
 
2.2. Sleep Disturbances  
 
In 2002, Soldatos et al. [13] developed a study involving 35 327 participants from 10 coun-
tries, including Portugal, with the aim of understanding what type of sleep disorders prevail in 
each country and to understand the impact that poor sleep quality has in people's capabilities 
during the day. Participants had to respond to a standardized questionnaire and were classified 
through the Athens Insomnia Scale (AIS) - if the score is greater than 6 it is considered insomnia 
- and the Epworth Sleepiness Scale (ESS) - if the total score is between 6 and 10 is considered 
sleepy, if the score is between 10 and 16 it is considered very sleepy and if is over 16 it is 
considered dangerously sleepy. The results of this study showed that 24% of the participants 
had poor sleep quality; 31.6% had an AIS score higher than 6, considered as insomnia; 11.6% 
had an ESS score higher than 10, considered very sleepy. This study showed that sleep-related 
problems are underestimated, noting that 91.6% of participants who reported that slept poorly 
had an AIS score of at least 4 indicating sub-threshold insomnia and 77.8% had a score corre-
sponding to insomnia. Among the 24% of the participants who considered that slept poorly, only 
30.7% reported that they had visited a physician (55.5% were Portuguese) and 31.4% reported 
that they had token sleeping medication (45.7% were Portuguese).The study also showed that 
sleep habits and sleep duration are similar in the 10 countries [13]. 
Figure 2.1.2 - Example of a normal hypnogram (taken from [9]) 
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This study showed that many people considered sleep disorders insignificant, however, 
when untreated they may be associated with hypertension, memory loss, strokes, type 2 dia-
betes and cardiac problems. Sleep disorders are classified in insomnia, parasomnia, circadian 
rhythm sleep-wake disorders, sleep-related breathing disorders, sleep-related movement dis-
orders, central disorders of hypersomnolence and other sleep disorders according to Interna-
tional Classification of Sleep Disorders (ICSD) [14], [15].  
• Insomnia is characterized by the difficulty that a person has in sleeping, whether in fall-
ing asleep or staying asleep [10], [14]. 
• Parasomnia is characterized by undesirable events that occur at onset, during sleep or 
during waking up [10], [14]. 
• Circadian rhythm sleep-wake disorders are characterized by changes in the circadian sys-
tem that may affect sleep regulation and can be classified in delayed sleep-wake phase, 
advanced sleep-wake phase, irregular sleep-wake rhythm, non-24-hour sleep-wake 
rhythm, shift work and jet lag [10], [14]. 
• Sleep-related breathing disorders are characterized by disturbances in breathing while 
the person is sleeping. Can be obstructive sleep apnea (OSA), central sleep apnea (CSA), 
hypopnea, respiratory-effort related arousal (RERA) sleep-related hypoventilation disor-
ders, chronic snoring, upper airway resistance syndrome and sleep-related hypoxemia 
disorder [10], [14], [16]. 
• Sleep-related movement disorders are characterized by movements during sleep and are 
classified in sleep-related movement disorder due to a medical disorder, sleep-related 
movement disorder due to a medication, propriospinal myoclonus at sleep, benign sleep 
myoclonus of infancy, sleep-related rhythmic movement disorder, sleep-related bruxism, 
sleep-related leg cramps, periodic limb movement and restless leg syndrome [10], [14].  
• Central disorders of hypersomnolence are characterized by sleepiness during the day 
[10], [14]. 
One of the most common disorder is sleep apnea, which affects about 40 million people in 
the US [17]. It is characterized by a stop of breathing for 10 or more seconds, and it can be 
repeated more than 20 times in an hour. There are two types of sleep apnea: CSA and OSA. CSA 
occurs when the brain does not transmit signals to the muscle to breathe [1] and OSA occurs 
when the upper airway is blocked [18] and is identified through increased respiratory effort 
[16], [2]. OSA is the most common sleep apnea and undiagnosed OSA affects 15% of the middle-
aged population [19]. Variations of heart rate and body movements during sleep are character-
istic in OSA. [18] This disorder is also known to increase the risk of cardiovascular disease and 
to cause impaired concentration, excessive sleepiness and snoring. Snoring is caused by the 
vibration of the upper airway’ structures and is a common breathing disorder that affects about 
20% to 40% of the population [2], [16]. 
 
 
2.3. Polysomnography 
 
Polysomnography (PSG) is the standard exam for sleep monitoring and for the diagnosis of 
sleep disorders, such as apnea [1], [19]. In this exam are monitored several parameters: elec-
troencephalogram (EEG), electromyogram (EMG), electrooculogram (EOG) electrocardiogram 
(ECG), airflow, thoracic and abdominal movements, oxygen saturation (SpO2), temperature and 
body position, with video and audio recording. PSG requires a specialist who places the sensors 
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correctly on the patient, is time consuming, expensive, and is not available in all hospi-
tals/sleep clinics. In addition to these disadvantages, the fact that this exam is performed 
outside the comfort of the patient's home, the use of so many sensors and the low freedom of 
movement created by wires that connect the electrodes to the equipment can negatively in-
fluence the quality of the patient's sleep, altering the results [1], [2], [19].  
 
 
2.4. Physiological parameters  
 
The parameters monitored in PSG are EEG, EMG, EOG, ECG, SpO2, airflow, thoracic and 
abdominal movements, temperature, body position and blood pressure. The EEG is character-
ized by rhythmic activities and transient events and can detect different stages of sleep. The 
EOG allows to detect eye movements and can distinguish between wake, REM sleep and NREM 
sleep. The EMG allows to distinguish between wake, REM sleep and NREM sleep, through the 
detection of muscle activity. The ECG, which detects cardiac activity, can also distinguish be-
tween wake, REM sleep and NREM sleep. Breathing monitoring allows to detect sleep-breathing 
disorders, such as apnea. The monitoring of oxygen saturation can detect oxygen supply failures 
during respiratory events such as apnea and through the monitoring of blood pressure it is also 
possible to detect apneas. Through the body movements it is possible to distinguish if the per-
son is awake or asleep. Lastly, the monitoring of temperature can distinguish between REM 
sleep and NREM sleep and allows to know when the onset of sleep occurs. 
 
The following sub-chapters will present the various parameters more exhaustively. 
 
2.4.1. Electroencephalogram   
 
Electroencephalogram (EEG) is able to monitor the electrical activity of the brain and is 
essential to identify different stages of sleep. The standard method for this monitoring is ac-
cording to the International 10-20 System [2], [20]. Nevertheless, according to the AASM crite-
ria, 3 EEG channels, such as F4-A1, C4-A1 and O2-A1, must be used [21]. It should be used 
Ag/AgCl or gold electrodes with low impedance. The Figure 2.4.1 shows the placement of the 
electrodes according to the 10-20 system [16], [22].   
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The EEG signal consists of rhythmic activities, characterized by delta, theta, alpha, beta 
and gamma waves, and by phasic activities, characterized by transient events such as K-com-
plexes, spindles, apex tips and sawtooth waves. Alpha waves (8-13 Hz, with a variable ampli-
tude of 10-120 μV) appear during the wake phase only with eyes closed. As sleepiness increases 
- beginning of the N1 phase - the frequency and amplitude of the alpha waves decrease. The 
amplitude of these waves increases when an eye open in the state of drowsiness. These waves 
also appear in micro-awakenings [2], [22]. 
 During N1 phase occurs a transition from alphas waves to theta waves (3-8 Hz, with ampli-
tude less than 75 μV). [3] Theta waves are abundant not only during the N1 phase, but also in 
the N2 phase, disappearing as sleep progresses to deeper phases and reappearing in the REM 
phase. The N1 phase is also characterized by apex tips (4-6 Hz, with an amplitude that must be 
twice as wide as the previous 5-second amplitude) which are mono or biphasic waves, with a 
negative component preceded by a positive component. In the case of biphasic, the positive 
component should be greater than 50% but less than 100% of the negative component [15], [22].  
During phase N2, besides the appearance of theta waves, also occurs the appearance of K-
complexes [2] which are events with a large negative wave amplitude followed by a slow posi-
tive wave. The duration of the initial peak must be less than the next peak and the amplitude 
should be twice as high as the previous 5 minutes with the amplitude of the positive component 
at least, 50% of the amplitude of the negative component. The minimum duration of the K-
complex is 0.5 seconds. This type of transient event has a lower incidence with age, dysthymia, 
alcoholism and abnormal sleep. Also, during this phase occurs the appearance of spindles that 
are outbreaks waves (12-14 Hz), with a duration of more than 0.5 seconds, with a minimum 
amplitude of 10 μV, fusiform morphology and may appear 3 to 8 times in a minute. Spindles 
may suggest the existence of a cortical or thalamic structural lesion when there is a persistent 
asymmetry in both amplitude and frequency [15], [16], [22], [23].  
N3 phase is characterized by delta waves (0.5-2 Hz, with an amplitude greater than 75 μV) 
[2]. 
Figure 2.4.1 - Placement of the electrodes to measure EEG according to the 10-20 system (adapted from 
[18]) 
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 Beta and gamma waves not provide information about sleep staging but are clinically im-
portant: beta waves (14-30 Hz) are visible in adults who are medicated with psychoactive drugs 
and toxic-dependent; gamma waves (25-100 Hz) are associated to the conscious perception 
[22].    
During REM phase, in addition to the appearance of theta waves, there can also appear 
sawtooth waves (2-6 Hz), which are outbreaks waves characterized, as the name implies, by a 
sawtooth morphology, with a duration of 10 seconds and with a progressive increase of ampli-
tude ( 20-100 μV) followed by a steep descent [22]. Different stages of sleep can be observed 
in the Figure 2.1.1.  
EEG is very important in sleep staging; however, it is inconvenient because many elec-
trodes are glued on the scalp. 
 
2.4.2. Electrooculogram  
 
The EOG signal has a range of frequency between 0.1 Hz to 20 Hz and a range of amplitude 
between 50 µV to 3500 µV [24], [25].  EOG can record, noninvasively, the movement of the 
eyes through electrodes placed around the eye. This recording is possible due to the potential 
difference between the retina, which is electrically positive, and the cornea, which is electri-
cally negative,- corneoretinal potential [22], [26]. Thus, when there is no eye movement, the 
potential is approximately equivalent in both directions and when there is movement, the po-
tential changes depending on the direction of the movements [26].  
Regarding the placement of the EOG electrodes, for detection of horizontal motion which 
provides a binocular recording, one electrode is placed 1 cm out and up the outer corner of 
one eye and the other electrode is also placed 1 cm out but down from the other eye. The 
electrodes may also be placed 1 cm below the outer corners of the eyes. The reference elec-
trode can be placed in the contralateral ear or on the middle of the forehead. The Figure 2.4.2 
shows the different placements of the electrodes [21], [22], [26]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.2 - Placement of the electrodes to measure EOG. In the left image is possible to observe one 
electrode placed 1 cm out an up the outer corner of the eye and other electrode placed 1 cm out and down 
from the other eye. In the right image is possible to observe the placement of electrodes 1 cm below the 
outer corners of the eyes. A1 and A2 represent the reference electrodes, R represents the right ocular and 
L represents the left ocular (adapted from [22], [26]) 
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There are several types of eye movements: rapid eye movements, slow eye movements and 
blinking movements. Rapid eye movements (> 0.6 Hz) are present during wakefulness and REM 
phase and are characterized by being irregular, with sharp edges and with an initial deflection 
of less than 500 milliseconds. Slow eye movements (0.2-0.6 Hz) are present in N1 phase [23] 
and are characterized by being regular, with sinusoidal contours and with an initial deflection 
greater than 500 milliseconds. Blinking movements (0.5-2 Hz) occur during wakefulness and are 
characterized by vertical conjugate eye movements [22]. 
The signal acquired can be influenced by changes in illumination, by movements of the head 
and eyelids and by the placement of the electrodes [26].      
 
2.4.3. Electromyogram 
 
The EMG can measure the muscular activity in the chin region. According to the AASM, three 
electrodes should be used: one electrode in the midline 1 cm above the lower edge of the 
mandible, another electrode 2 cm below the lower edge of the mandible and 2 cm to the right 
in relation to the midline and the third electrode should be placed the same as the previous 
one, but 2 cm to the left in relation to the midline. Nevertheless, it may be necessary to monitor 
the EMG in other places, for example in the masseters to detect episodes of bruxism, in the 
anterior tibia to detect periodic movements of the lower limbs and in the extensor of the fingers 
or toes. In Figure 2.4.3 is possible to observe the placement of the EMG electrodes in different 
parts of the body [22]. 
 
Muscle activity is higher during wakefulness, decreases with sleep depth, and is lower or 
absent during REM sleep [20]. 
 
2.4.4. Electrocardiogram  
 
The ECG is able to detect heart rate (HR) changes and can provide a HR standard that can 
detect OSA. The analysis of the variation of heart rate provide information about the circadian 
rhythm of sleep.  
The normal range of heart rate among adults is 60-100 beats per minute (bpm), being an 
indication of disease if its value is outside this range, namely bradycardia for lower values, or 
Figure 2.4.3 - Placement of the electrodes to measure EMG. In the image to the left it is possible to 
observe the placement of electrodes in the area of the ment. In the central image it is possible to observe 
the orientation of the electrodes in the anterior tibial zone and in the right image in the masseter zone. 
A1 and A2 represent the reference electrodes. (taken from [20]) 
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tachycardia for higher ones. The ECG waveform can be observed in the Figure 2.4.4 [22] and 
the heart rate variation during sleep can be observed in the Figure 2.4.5 [27]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One important parameter that can be extracted from the ECG signal is the heart rate vari-
ability (HRV). The HRV allows to evaluate the autonomic nervous state through the variations 
between consecutive heartbeats and has a frequency domain and a time domain. With the 
frequency and time domain variables it is possible to perform a sleep staging.  
  Through the time domain method it is possible to calculate the mean NN interval and the 
standard deviation of the NN interval (SDNN)[28], which are the most common time domain 
variables used to described the sleep stages according to Jiang et al. [29] Vigo et al., [30] 
showed that the mean NN interval was lower during wake time than during sleep time and was 
greater during deep sleep than during REM sleep. Kesek et al., [31] showed the same differences 
as the previous article in the mean NN interval and add that SDNN is higher during wake time 
than during sleep time, and deep sleep has lower values compared to other phases. Regarding 
the heart rate, Trinder et al., [32] and Ako et al., [33] showed that is higher during the wake 
time than during sleep time, being lower in the NREM phase compared to the REM phase.   
Through the frequency domain method it is possible to evaluate the cardiac system during 
sleep since the spectral power in specific band frequencies is related to the activity of the 
Figure 2.4.4 - The ECG waveform (adapted from [22]). 
Figure 2.4.5 - Variation of the heart rate throughout the different stages of sleep (taken from [27]) 
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sympathetic and parasympathetic nervous system: the spectral power in high frequency (HF, 
0.15-0.4 Hz) is associated with the activity of the parasympathetic nervous system and the 
spectral power in low frequency (LF, 0.04-0.15 Hz) is associated with the activity of the sym-
pathetic and parasympathetic nervous system. Versace et al., [34], Kesek et al., [31] and Opav-
sky et al., [35] showed that the LF component is higher in the REM phase compared to the NREM 
phase, and in this last phase the LF component is lower in the deep sleep. Relatively to HF 
component, they showed that is lower during wake time than during sleep time, being higher 
during NREM sleep (light sleep) than during REM sleep. Finally, they also showed that the ratio 
between low frequency and high frequency is higher during REM sleep than during wake time 
and is lower during deep sleep. In the Table 2.4.1 it is possible to verify the sleep staging based 
on the time and frequency domain variables.  
 
 
Table 2.4.1 - Sleep staging based on the time and frequency domain variables. ‘+’ represents that the 
variable is lower in that sleep stage and ‘++++’ represents that the variable is higher in that sleep stage. 
[31], [34], [35] 
 
Respiration can also be derived from the ECG, an important parameter for detecting apneas 
and other respiratory disorders. That detection is possible due to cardiac electrical axis changes 
during respiration, with periodic attenuation of the ECG amplitude with the respiratory effort 
or through periodic changes that occur in the RR interval: during inspiration, intrathoracic pres-
sure decreases, venous return increases, HR increases and consequently RR interval decreases; 
during expiration, frequency decreases and RR interval increases [2].    
 
 
2.4.5. Respiration  
 
Breath monitoring during sleep can detect sleep-breathing disorders such as apnea. Nasal 
pressure and/or airflow, respiratory effort and oxygen saturation are the respiratory parame-
ters recorded during PSG [22].  
Plethysmography and pneumotachography are standard methods for detecting sleep events, 
however, both methods are not suitable for use in PSG. Since, in the plethysmography exam, 
the patient must be in a chamber suitable for that purpose, and in pneumotacography exam, a 
face mask is used to measure pulmonary volume, which is considered intrusive. Regarding the 
measurement of respiratory effort, esophageal pressure is the most reliable method because 
can record oscillations of intrathoracic pressure during apnea due to respiratory effort, how-
ever, it is a very invasive and complex method [2], [22], [36].   
Thus, there are other methods that can be incorporated in the PSG, such as thermistors or 
thermocouples, nasal cannula pressure transducers, respiratory inductance plethysmography 
Time and Frequency 
domain variables 
WAKE NREM Phase REM Phase 
Light Sleep Deep Sleep 
Mean NN interval + ++++ +++ ++ 
SDNN ++++ ++ + +++ 
LF component +++ ++ + ++++ 
HF component + ++++ ++ +++ 
LF/HF +++ ++ + ++++ 
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(RIP), impedance plethysmography (IP) and piezoelectric sensors. Thermistors and thermocou-
ples detect differences of temperature and therefore can detect inspiration and expiration, 
since the air is hotter during the expiration and cooler during the inspiration, however, they do 
not provide quantitative measurements of the airflow, not being able to detect hypopneas. 
Nasal cannula pressure transducers provide a linear approximation of airflow but cannot accu-
rately distinguish apnea from hypopnea. The RIP can measure, through the self-inductance, 
changes in the thoracic area, providing a measurement of the tidal volume, however, in apnea 
situations this measurement becomes less correct, so it is not often used. The IP can measure 
changes in chest volume due to respiration through changes in electrical resistance. And, fi-
nally, there are piezoelectric sensors embedded in straps that measure the circumference of 
the chest and abdomen, however these sensors are sensitive to artefacts [2], [22], [36]. 
Expiratory carbon dioxide is an important parameter that should be monitored since it pro-
vides information about the carbon dioxide concentration and can indicate if airways are ob-
structed. Nevertheless, there are some disadvantages, namely the need for a mask and the fact 
that it is not possible to measure it during apnea. Infrared sensors are used to record this 
parameter [22]. 
 Although the airflow and respiratory efforts are easy to monitor and apply, they can be 
affected by the movement of the body, so this is a parameter that must always be taken into 
account [18].  
 
2.4.6. Blood Gases  
 
Monitoring oxygen saturation (SpO2) is of paramount importance as it allows the detection 
of oxygen supply failures during respiratory events such as apnea. Oxygen desaturations of more 
than 2-5% are considered indicator of OSA [2].  
The oximeter is an optical-electronic device that is generally used to monitor SpO2 [22], 
through the difference in light absorption of two different wavelengths, [37] that is, the oxi-
meter measure the absorption of the specific wavelength in oxyhemoglobin (which transport 
the oxygen) and compare with the absorption of the specific wavelength in deoxyhemoglobin 
(without oxygen). Through the difference between oxyhemoglobin and deoxyhemoglobin it is 
possible to calculate the amount of oxygen contained in the blood [38]. This type of device is 
based on photoplethysmography (PPG), a non-invasive optical method. Its signal is constituted 
by the AC component that provides information about the absorption due to the pulsatile arte-
rial blood and, consequently, provides information about heart rate since the arterial blood 
volume is synchronous with the heartbeat, and by the DC component that provides information 
about tissue and mean blood volume. The DC component may suffer variations due to vasomotor 
activity, vasoconstriction waves and respiration [39]. The figure 2.4.6 represents a PPG wave-
form.  
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There are two types of PPG: reflectance and transmittance. In both are needed two light 
emitting diode (LED), and a light detector, which is usually a photodiode. One LED emits infra-
red light (940 nm) which is absorbed by the oxyhemoglobin and other LED emits red light (660 
nm) which is absorbed by deoxyhemoglobin. The amount of light absorbed by the oxyhemoglo-
bin is proportional to the concentration of oxyhemoglobin in the blood vessel and each oxyhe-
moglobin absorbs some of the light, thus, more oxyhemoglobin absorbed more light, according 
to the Beer’s Law. The photodiode measure the detected light and convert it into an electrical 
voltage. [38] In reflectance, the source and the light detector are placed on the same side of 
a peripheral part of the body, such as fingertip, earlobe and foot, in the transmittance they 
are placed on the opposite side of any part of the body, usually on the forehead [39]. 
During systole occurs an increase of oxyhemoglobin in the tissue that will absorb the infra-
red light, and consequently, reduces the amount of light that is detected by the photodetector 
[38]. 
When the source emits light for one part of the body, part of the light is absorbed, another 
is transmitted, and another is reflected. In the case of reflectance, the photodetector detects 
reflected light [39] and in the case of transmittance, the photodetector will detect the trans-
mitted light [37].  
Oximeters can provide false results due to movement artefacts and poor contact between 
the sensor and the skin surface [2]. Furthermore, results may also not be correct since dyshe-
moglobinemias may not be detected and desaturations may not occur during an apnea situation 
[22].  
 
2.4.7. Arterial Pressure  
 
The blood pressure (BP) is an important parameter that should be monitored because many 
people with hypertension are asymptomatic [3]. The BP changes during sleep and apnea, in-
creasing during the REM phase and during apnea. Although there are some methods for moni-
toring BP, none is ideal for the record during sleep: one method is through an inflatable arm-
band; however, it disturbs sleep, it does not make a continuous recording and not detect sudden 
alterations; the other method is through an intra-arterial catheter that despite providing a 
continuous record, is invasive [22]. 
Figure 2.4.6 - Representation of a PPG waveform (taken from [116]) 
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To minimize the discomfort during sleep caused by these methods, the BP can be estimated 
using pulse transit time (PTT). The PTT can be defined as the time between the ECG R peak 
and the corresponding maximum slope of PPG wave [3]. For each R peak of the ECG, the nearest 
maximum slope of the PPG is detected and, then, the PPT value is calculated, which can only 
be validated if it is within 20 % to 70 % of the RR interval [40].  
 
2.4.8. Peripheral Pulse  
 
The peripheral pulse wave is created during systole, when blood is ejected from the heart. 
[41] The peripheral pulse can be extracted through oximetry, through the reflectance or trans-
mission of IR and Red light. It can detect changes in the volume of peripheral tissue [41], and 
can provide information on peripheral vasodilation and RR intervals [22].   
 
2.4.9. Body Position and Movements  
 
The movement and the position of the body are also important factors in assessing sleep 
quality. Actigraphy is a non-invasive and inexpensive method that use the accelerometer to 
detect the movements while the person is sleeping. Through this detection it is possible to 
predict whether the person was sleeping or awake. The position of the body is an important 
parameter, since the severity of OSA varies according to the position of the person while sleep-
ing. A study by Ozeke et al. [42] showed that sleeping in the supine position causes a higher 
Apnea Hypopnea Index (AHI) and sleeping on the left side has a higher AHI compared to sleeping 
on the right side. To evaluate this parameter, a study by Kesteren et al. [43] used two position 
sensors, one placed in the centre of the forehead and the other in the trunk, since the supine 
position of the head and trunk influence the AHI in OSA. The position sensors used in the study 
by Kesteren et al. [43] were created by Sleepsense, St. Charles, IL, USA, and provide a signal 
which is directly related to sleeping position. 
 
2.4.10. Core Body Temperature  
 
 Core body temperature (CBT) occurs as a combination between production and heat loss: 
when the heat production is greater than its loss, the CBT increases and when the heat produc-
tion is lower than its loss, the CBT decreases [44]. 
The circadian rhythm of CBT is related to the sleep period: at the beginning of sleep, CBT 
decreases markedly with an increase in blood flow and, consequently, occurs a loss of heat 
through the transfer of heated blood to blood vessels, especially to the ones located in the 
distal areas of the skin, such as in the hands, since they have a faster heat loss; and at sleep 
interruption, CBT increases [44], [45]. It should be noted that the onset of sleep occurs 5-6 
hours before the minimum value of CBT, and the awakening occurs 1-3 hours later  [44]. A study 
by Burgess et al. [46] showed that the decrease of the CBT is related to the NREM sleep, in the 
transition between the NREM sleep to REM sleep a slight increase occurs and decreases again 
in the transition from the REM sleep to the NREM sleep [46], [47]. 
When the rhythm of CBT is delayed or advanced relative to the period of sleep, can occur 
difficulties in falling asleep - insomnia - or in maintaining the sleep. This happen because, under 
these conditions, the rhythm of the CBT may coincide with the time at which the onset of sleep 
is delayed, 6-9 hours before the minimum value of CBT, causing difficulties in falling asleep. 
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Or may coincide with the associated height upon awakening that occurs in the morning, 4-7 
hours after the minimal value of CBT, causing problems in maintaining the sleep [44]. 
 
2.4.11. Skin Temperature  
 
The circadian rhythm of the skin temperature is also related to the sleep period. It varies 
according to the ambient temperature and is inversely related to the CBT rhythm [44].  
Some studies showed that the increase in skin temperature may be related to the onset of 
sleep. Van den Heuvel et al. [48] showed that the increase in temperature of the hands and 
feet (distal temperate) is related to the onset of sleep. Lack et al. [49], showed a rapid increase 
in finger temperature before sleep onset and, consequently, a decrease in CBT. Taking these 
studies into account, Raymann et al. [45] have shown that increasing distal temperature, par-
ticularly in the foot, in young adults, may increase the ease of falling asleep. Older individuals 
have a lower ability to raise distal temperature. A study by Roy et al. [50], goes further and 
shows that for people without sleep problems, the increase of distal skin temperature increases 
REM sleep and suppresses light sleep, and the increase of proximal skin temperature (such as 
the abdominal area) increases deep sleep and suppresses wakefulness. 
 In conclusion, the increase of skin temperature is related to sleep onset and the manipula-
tion of the distal and proximal skin temperature can improve the sleep.  
 
 
 
 
39 
 
 
 
 
4,0 cm  
  
Chapter 3 
 
 
Wearable Sleep Devices 
 
 
 
Wearable devices collect sensors data, continuously and non-invasively, on a specific and 
small part of the body. These sensors can be placed in different parts of the body or can be 
inserted in the fabric of the garment, which makes the monitoring of vital signs more comfort-
able [3] The use of this type of device during sleep allows a simpler and less disturbing moni-
toring comparing to PSG, and since it is a continuously monitoring, can be a method of inter-
vention, allowing for a quick intervention if necessary.  
These devices must be low power consumption, comfortable, easy to use, light weight, 
should be safe to use, the sensors should work for long periods of time and the system imple-
mented in the device must guarantee security and confidentiality in the collected data [18], 
[51]. 
 
This chapter presents the description of a generic architecture of a wearable device and a 
study of some commercial devices and prototypes devices used to monitor sleep. 
 
3.1. Device Architecture 
 
The generic device architecture is mainly constituted by three modules. The first one is 
constituted by sensors that capture the vital signs of the user, for example, motion, pressure, 
biometric and temperature sensors. This first module is defined as the Body Area Network 
(BAN), which is a network with the sensors around the body.  Then, the electrical signals are 
sent to a central unit, where signal processing takes place (amplification, filtering and conver-
sion of the analog to digital signal through an A/D converter). This is the second module. The 
processed signals can then be stored in the central unit or can be sent to other device for offline 
or real-time analysis, respectively – third module. Figure 3.1.1 shows the different components 
of the generic architecture of a wearable device.  
 
In the following sub-chapters the Body Area Network (BAN) and the central unit will be 
described in more detail in order to clarify the architecture of a wearable device, as well as 
the differences between real-time and offline monitoring.    
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3.1.1. Body Area Network 
 
The term Body Area Network (BAN) is sometimes mistaken with the terms Body Sensor Net-
work (BSN) and Wireless Sensor Network (WSN). These three terms can be used in different 
types of wearable devices architecture, but they do not have the same meaning, so their re-
spective definitions will be clarified next. 
 
The BAN is a network that connect all the sensors, which are placed around the body, to a 
main unit. The term BSN is used when each node from the connecting network contains a med-
ical device or a sensor with a sensing unit, with more than just the sensor. The term WSN is 
defined as a large number of low-power, low-cost and tiny sensor nodes and each node has a 
set of components, such as sensors, microcontroller, and memory. Besides that, each node has 
the capacity of sensing, computing, storage and communication [52]–[54].  
 
3.1.2. Central Unit 
 
The vital signs collected by the sensors are usually transmitted to the central unit through 
wires, making the wearable device cheaper and simpler. This type of transmission is short-
range and can affect the free movement of the user due to the loose wires. One possible im-
provement is the use of conductive wires that transmit the information provided by sensors 
embedded in clothing [52], [53]. The signal processing occurs in the central unit and includes 
amplification and/or filtering and conversion of the analog signal to digital. The signal pro-
cessing can also be made in other device after the transmission of data.      
 The data in the central unit can be stored through, for example, an SD memory card for 
later analysis or through a wireless transmission. The central unit can also receive data from 
online monitoring devices, allowing the storage of these data [51], [55], [56]. This transmission 
is due through wireless communication. Examples of wireless connection channels are Blue-
tooth, Wi-Fi and ZigBee [3], [54], [55]. Bluetooth enables a short-range radiofrequency connec-
tion between portable and/or non-portable devices. It is low-cost and low-power consumption 
(consumes about 350 mW). The ZigBee [55] is a low-cost and ultra-low power consumption 
technology (about 100 mW) that consumes less power compared to Bluetooth, but instead has 
a lower data transfer rate. It also has the disadvantage of short-range communication. Wi-Fi 
allows a higher data transfer rate, however, it is the most energy-consuming, about 4 W [3], 
[10]. 
Figure 3.1.1 - Wearable device architecture (adapted from [55], [56]) 
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3.1.3. Real Time Monitoring versus Offline Monitoring  
 
Real-time monitoring of the user’s vital signs allows the user to not need to be in a hospi-
tal/health center confined to a machine which perform the monitoring. The data collected by 
the sensors are then transmitted by wireless to a user's portable device giving him information 
about his status and alert him to possible anomalies. The data collected can also be sent to the 
medical center. This type of monitoring enables an immediate real-time response to an action 
[24]. 
   In offline monitoring, the vital signs data is stored, for example, on an SD memory card 
for later analysis by the user or by the medical center. Contrary to real time monitoring, offline 
monitoring provides a slower response to a given action [24] and does not allow for an early 
detection of disease. 
 
3.2. Wearable Sleep Devices - State of Art 
 
Wearable sleep devices have been used as an alternative for PSG since are less expensive 
and can monitor the user’s sleep in his comfort of house. According to American Sleep Disorders 
Association (ASDA) devices which can do a portable monitoring are classified in type II, III or IV 
since type I device is the standard PSG and is consider the reference to the other devices. Table 
3.2.1 represents the ASDA classification of the four types of devices according to their respec-
tive sleep records, taking into account the following parameters: have or not have supervision, 
presence or absence of EEG channels, the number and type of variables monitored and their 
respective function [16], [18], [19], [57]. According to the Agency for Healthcare Research and 
Quality (AHRQ), devices which do not have the characteristics to be type III devices are consider 
type IV [57].  
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Table 3.2.1 - Classification of different types of devices to monitor sleep (adapted from [16], [18], [19], 
[57]) 
 Type I 
Standard PSG 
Type II 
Comprehensive 
portable PSG 
Type III 
Portable sleep ap-
nea testing 
Type IV 
Continuous re-
cording of pa-
rameters 
 
 
Parameters 
monitored 
EEG, EOG, EOG, 
chin and tibia EMG, 
ECG or heart rate, 
airflow, respiratory 
effort and oxygen 
saturation 
EEG, EOG, EOG, 
chin and tibia EMG, 
ECG or heart rate 
airflow, respiratory 
effort and oxygen 
saturation 
Minimum of four 
channels, including 
respiratory move-
ment or effort, air-
flow, ECG or heart 
rate and oxygen 
saturation 
 
 
Minimum of one 
channel, mainly 
oxygen saturation 
Supervision Yes No No No 
 
 
 
 
Function 
 
Calculation of total 
sleep time; Identifi-
cation and quantifi-
cation of different 
stages of sleep; De-
tection of sleep dis-
turbances 
Calculation of total 
sleep time; Identifi-
cation and quantifi-
cation of different 
stages of sleep; De-
tection of OSA, leg 
movements, awak-
enings and respira-
tory abnormalities 
 
 
 
 
Detection of sleep 
apnea; 
 
 
 The high technical complexity and the low technical reliability led to the limited use of 
these devices. It is therefore necessary that ambulatory sleep monitoring devices be simple and 
technically reliable so that they can be used for possible diagnosis [19]. 
 
3.2.1. Commercial Devices   
 
The actigraphy has been used for ambulatory monitoring, since it is an easy and cheap 
method to measure the duration of sleep, through the movements. However, this type of device 
cannot measure parameters such as heart rate and breathing, and is conditioned to acceleration 
measures, so it can induce some classification errors in activities with little movement, such as 
reading [58]. Fitbit Flex is an example of a commercial device that uses the method of actig-
raphy through an accelerometer on a bracelet that records movements of the body. It can 
detect when the user is awake or sleeping, records total sleep time and sleep latency but not 
extract more information about sleep staging [59]. Like FitbitFlex, UP3 from Jawbone is a 
bracelet which can measure the movements of the body through an accelerometer but can also 
records respiration and heart rate through a bioimpedance sensor, galvanic skin response and 
body temperature. This device can detect wake, REM, light sleep and deep sleep, although it 
is not very comfortable because the bracelet has to be tightest in order to be able to measure 
the physiological parameters and is not very precise [60], [61]. Another device that can detect 
wake, REM, light sleep and deep sleep is a watch named Basis Peak from Intel. It has an accel-
erometer to measure the movements of the body, an optical sensor to records heart rate, a 
galvanic skin response sensor and a body temperature sensor. Although this device has a good 
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battery life and could detect sleep stages, it was withdrawn from the market in 2016 by reports 
of overheating of the watch [60], [62]. 
BodyMotion Inc. has developed a wearable device SenseWear Pro2 Armband which consists 
of a 2-axis accelerometer, a skin temperature sensor, a heat flux sensor and a galvanic skin 
response sensor [63]. This device was subsequently tested to verify if it could estimate the total 
sleep time of users with obstructive sleep apnea and was found that its estimative agreed with 
the results of the PSG. Has also been found that, because the device is used on the arm, it is 
less affected by wrist movements that can lead to false results. However, this device cannot 
detect sleep phases [64], [65]. 
In order to measure other signals that are correlate with sleep quality, such as heart rate 
variability and respiration, there are some commercial devices, for example, Equivital system 
[66] and Hexoskin smart t-shirt [67]. The first one is a belt around upper chest that measures 
a respiration effort through a strain gauge, a two-lead ECG, 3-axis acceleration and skin tem-
perature [58]. Hexoskin smart t-shirt incorporate two magnetic sensors to measure breathing 
rate, one-lead ECG and 3-axis accelerometer. Both devices can distinguish between wake and 
sleep and between light sleep and deep sleep, can detect disruptions in breathing, movements 
and positions during sleep [68]. There is a commercial t-shirt named Somnus Sleep Shirt from 
Nyx Device [69] which can detect if the user is awake or sleeping and can detect the phase of 
sleep  – REM, light sleep and deep sleep – only with the measurement of the respiration through 
three capacitive sensors – two of these sensors are placed in the abdomen and one in the chest. 
[70] In the Figure 3.2.1 it is represented the commercial wearables devices described above: 
Fitbit Flex, UP3, Basis Peak, SenseWear Pro2 Armband, Equivital System and Hexoskin Smart T-
Shirt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) (B) (C) 
(D) 
(E) (F) 
Figure 3.2.1 - Commercial wearable devices. (A) Fitbit Flex [59], (B) UP3 [61], (C) Basis Peak 
[62], (D) SenseWear Pro02 Armband [63], (E) Equivital System [53] and (F) Hexoskin Smart T-
shirt [67]. 
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Another type of commercial device is patch. One example is the VitalPatch [71] from Vital 
Connect which is worn on chest and has a duration of more than 4 days. This adhesive patch 
records heart rate with ECG electrodes, respiratory rate, skin temperature with thermistor and 
body movements with 3-axis accelerometer. This device can distinguish wake, sleep, REM and 
NREM sleep, however it does have some disadvantages such as the patch may peel off and the 
sensor battery may suffocate if the patient sleeps in a prone position [72], [73].  
NeuroOn Open [74] is a sleeping mask that has a 3-axis accelerometer which records body 
movement, temperature sensor, EOG and EEG sensors and a pulse oximetry sensor. This sleep-
ing mask can sleep track through the EEG and can detect apnea through the pulse.  
SmartSleep from Philips is a headband recently released in the market (2017). It uses an 
EEG to detect deep sleep (N3), and when N3 phase is detected, SmartSleep delivers optimized 
sound to enhance this stage. This device was designed to improve sleep efficiency ideally for 
people who sleep less than 7 hours per day and wake up tired but not have problem falling 
asleep or staying asleep. This product should not be used by hearing impaired, since the volume 
of this device does not exceed 80 dB [75]. The devices described above are type IV devices 
according to the AHRQ [57]. 
There are some commercial type III devices, for example, APV2, Sleep Scout from Cleveland 
Medical and ApneaLink by ResMed. APV2 can diagnose obstructive sleep apnea through the 
measurement of oxygen saturation and heart rate with a pulse oximeter, orinasal air flow and 
snore with a pressure cannula, respiratory effort in thorax and in abdomen with accelerometer 
and strain gauge, respectively, and body position with an accelerometer. This device although 
limited by the number of channels, is easy to use and has a good technical reliability [19]. 
ApneaLink [76] can report apnea, hypopnea, flow limitation and snoring through the measure-
ment of nasal airflow with a cannula, respiratory effort and heart rate with a belt around the 
chest and oxygen saturation with an oximeter. However, it has been reported that this device 
can overestimate the Obstructive Apnea Hypopnea Index (OAHI) probably because it scores 
obstructive events that would not be scored on PSG, for example, events during wakefulness. 
Therefore it was important that this device has a sensor to detect wake and sleep time, such 
as actigraphy [77]. Sleep Scout [78] records thoracic and abdominal effort, body position, air-
flow, snore, pulse oximetry, ECG and EMG [51]. 
AlicePDx from Philips Respironics is a type II-III device which records respiratory effort with 
chest and abdominal belts, airflow and pressure with the cannula and thermistor, oxygen sat-
uration with an oximeter and body position, and can also records EEG, EOG, EMG and ECG. This 
device is easy to use and has a code of colours around the device that indicate where to connect 
the various sensors. In relation to the data recordered, it is stored on a storage card, but the 
device can also be connected directly to a computer so that the data can be viewed in real 
time. AlicePDx can detect different stages of sleep and can report sleep apnea and sleep-
disordered breathing [10], [79]. Embletta X100 from Embla is a type II device that measures 
EEG, EOG, EMG, ECG, respiratory effort with abdominal and thoracic bands, airflow with nasal 
cannulas, oximetry and body position [19]. This device can monitor different stages of sleep.  
Park et al., demonstrated that the Embletta X100 scoring system does not provide an accepta-
ble and accurate OSA diagnosis. [80] Another example of a type II commercial device is Somté 
PSG from Compumedics [81] which records six EEG channels, two EOG channels and two chin 
EMG channels, ECG, airflow through the pressure transducer, snore, respiratory effort with 
abdominal and chest bands, body position and oxygen saturation with oximeter [57] . Figure 
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3.2.2 represents the following commercial wearable devices: SmartSleep, VitalPatch, NeuroOn 
Open, Sleep Scout, ApneaLink, AlicePDx, Embletta X100 and Somté PSG  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Table 3.2.2 classifies the described commercial devices according to the ASDA classifi-
cation. As can be seen in the table, about 57% of the analysed commercial devices are type IV 
because they have fewer sensors and are easier to monitor compared to other types of devices.   
 
 
 
 
 
 
 
(A) (B) (C) 
(D) (E) (F) 
(G) (H) 
Figure 3.2.2 - Commercial wearable devices. (A) Embletta X100 [19], (B) NeuroOn Open [74], (C) Sleep-
Scout [78], (D) ApneaLink [76], (E) Somté PSG [81], (F) AlicePDx [79], (G) VitaPatch [71] and (H) Smart-
Sleep [75] 
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Table 3.2.2 - Classification of different commercial devices according to the ASDA classification 
Type 
II II/III III IV 
 
 
 
  
 
Somté PSG 
 
 
 
 
 
Alice PDx 
 
APV2 
 
Fitbit Flex 
UP3 
 
SleepScout 
 
Basis Peak 
SenseWear PrO2 
Armband 
 
ApneaLink 
 
Equivital System 
Hexoskin Smart 
T-Shirt 
 
Embletta X100 
Vital Patch 
NeuroOn Open 
SmartSleep 
 
3.2.1.1. Vital Jacket®    
 
VitalJacket® is the first certified wearable medical device, designed and developed at the 
University of Aveiro and licensed by the company Biodevices, S.A. that combines knowledge in 
the area of textile and microelectronics, in order to allow the monitoring of vital variables. 
This system is a T-shirt with built-in sensors, developed for various clinical situations, either in 
hospitals or at home, for people who require frequent or continuous monitoring of vital signs, 
such as electrocardiogram, heart rate, activity and posture, and body temperature. The t-shirt 
is washable, easy to use and has disposable electrodes. The data acquired by this device is 
transmitted via Bluetooth, which enables real-time monitoring, and can also be stored on a SD 
memory card for offline monitoring [5]. 
Although the VitalJacket® is not specified for sleep monitoring, it has sensors such as elec-
trocardiogram, 3-axis accelerometer and temperature sensor, which can be used for this type 
of monitoring. In addition, this device can be adapted to acquire other vital signs, such as 
oxygen saturation and electrooculogram. Due to these characteristics, it will be possible to 
develop a prototype of a wearable device that will extend the VitalJacket®, named VitalSleep. 
The Figure 3.2.3 represents the VitalJacket® wearable device.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3 - VitalJacket® commercial device [5]. 
 
47 
Wearable Sleep Devices - State of Art 
 
 
3.2.2. Prototype Devices 
 
Some type IV devices have been developed over the years, examples of that are the follow-
ing devices. Sukuzi et al., [82] developed a watch (Prototype 1) that records wrist movements 
with a 3-axis accelerometer and pulse wave through photoelectric sensor. It can detect wake, 
REM and NREM sleep and has the advantage that the prototype can be small and simple due to 
the signals that it measures. Although, it cannot detect apnea and the algorithm only applies 
to healthy individuals. Lee et al., [83] also developed a wrist shaped device (Prototype 2) that 
records heart rate through photoplethysmography and movement using an actigraphy. This de-
vice can only detect wake and REM sleep phase. Chang et al., [84] developed a wearable device 
to be placed on the chest (Prototype 3) with a 3-axis accelerometer and ECG to detect the 
sleeping position, sleep stages and sleep disorders such as obstructive sleep apnea. In order to 
detect obstructive sleep apnea, Rofouei et al., [85] created a wearable neck-cuff (Prototype 
4) which records oxygen saturation and heart rate through an oximetry connected to the ear-
lobe, respiratory sounds with a microphone, body movements and head position with a 3-axis 
accelerometer. The use of a microphone to records respiratory sounds has the disadvantage of 
only providing a relative value. Wongdhamma et al., [86] developed a type III device: a shirt 
(Prototype 5) incorporated with 3-lead vectorcardiogram, 12-lead ECG, an oximetry and a 
phonocardiography transducer which capture cardiac sounds and respiratory sounds, such as 
snoring. This device can detect obstructive sleep apnea and cardiovascular diseases. The use 
of a phonocardiography has the same disadvantage that had already mentioned in the wearable 
neck-cuff device. Oh et al., [1] also developed a type III device (Prototype 6). This prototype 
can monitor sleep apnea and records ECG signal, body position with a gyroscope, respiratory 
effort with piezoresistive sensors, nasal airflow with pressure transducers and oxygen satura-
tion with an oximetry. The Table 3.2.3 classifies the described prototypes devices according to 
the ASDA classification. Like commercial devices, most of the prototypes of the analysed de-
vices are also type IV. 
 
Table 3.2.3 - Classification of different prototypes devices according to the ASDA classification 
Type 
III IV 
Prototype 5 [86] 
 
Prototype 1 [82] 
Prototype 2 [83] 
Prototype 6 [1] Prototype 3 [84] 
Prototype 4 [85] 
 
The use of many sensors provides more data and increases the reliability of the sleep quality 
examination; however, it can harm the patient while sleeping and, consequently, can influence 
the results.    
Through the analysis of existing wearable commercial devices and prototype devices it is 
possible to conclude that type IV devices are the most common. That is because they have few 
sensors, are easy to monitor and easy to use. Also through that analysis it is possible to conclude 
that the most common parameters monitored on that wearable devices are the body move-
ment, ECG signal and breathing [3].  
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3.3. Market and Trends 
 
The concern of daily monitoring of health status has been increasing. Thus, several devices 
have been developed for real-time monitoring [87]. 
Developments in small devices and in mobile computing have increased the interest in wear-
able technology. Wearable devices are comfortable, easy to use, non-invasive and allow con-
tinuous monitoring during a long period of time, for these reasons they have been growing in 
the economy [4]. It is estimated that in 2025 there will be about 3 billion wearable sensors 
[51]. And it is estimated that by 2022 the wearable technology market will reach $ 57,653 
million, almost 3 times more than in 2016 [88]. Figure 3.3.1 shows a graphic with the estimated 
growth of revenue from wearable devices from 2015 to 2016 [89].  
 
 
 
 
 
 
 
 
 
 
 
 
 
The global smart textiles market has also increased, with an estimated $1500 million in 
2020, more than $1000 million compared to 2012 [90]. 
 Specifically in the sleep area, a study by Légel et al., showed that 25.6 million people in 
Japan, 82.3 million people in Western Europe and 131.3 million people in the USA suffered from 
sleep problems [91]. It is estimated that millions of Americans suffer from sleep disorders that 
are undiagnosed or untreated, for example, about 40 million suffer from sleep apnea and many 
of these people have this disorder undiagnosed [17].  
 The PSG can monitor the sleep quality; however, it is expensive, invasive and is not avail-
able in all hospitals/health centers. At least 2 300 PSG per 100 000 people must be made in 
USA, however, only 425 PSGs are made [92]. Thus, wearable devices appear as a possible solu-
tion for ambulatory sleep monitoring. In 2014, the global market for sleep testing at home 
reached about $36.8 million [17]. In 2017 it was estimated that the revenues reached $3 115 
million only considering the US [93].      
 
Through the analysis of these statistics, it is possible to conclude that the use of wearable 
devices will increase. Advances in the textile area and in mobile computing make this type of 
healthcare technology cheaper, simpler, smaller, more comfortable and with more reliable 
results. In addition, it is notable the large number of people who suffer from both diagnosed 
Figure 3.3.1 – Estimated growth of revenue from wearable devices between 2015 and 2016 (taken 
from [89] 
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and undiagnosed sleep disorders. Therefore, the investment in the development and improve-
ment of wearable devices to ambulatory sleep monitoring should continue.  
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Chapter 4 
 
 
VitalSleep: A wearable sleep system 
 
 
 
VitalSleep is a new concept of a wearable technology to monitor sleep. VitalSleep system 
consist in the development of the hardware, acquisition of the sleep recording in real-time and 
the development of the sleep stage processing unit that comprises signal analysis, design of an 
algorithm to analyse the sleep stages and the evaluation of the algorithm.  
To better understand which are the essential signals to monitor sleep, a study of physiolog-
ical parameters measured in the polysomnography was made as can be seen in the Chapter 2 
“Sleep Characteristics and Physiological Parameters Monitored”. With this study it was con-
cluded that the EEG signal has more information to monitor sleep. ECG and EOG are two signals 
that can also monitor sleep, although not so complex and with less information comparatively 
to EEG signal. Oxygen saturation is also an important parameter in sleep monitoring, because 
can detect oxygen supply failures during respiratory events such as apnea. Another study was 
made to understand what type of physiological variables are often monitored in commercial 
sleep wearable devices, as can be seen in Chapter 3 “Wearable Sleep Device – State of Art” and 
it was concluded that the main variables monitored are the ECG signal, body movements and 
breathing. Considering the time to do this work and the complexity of all signals, it was chosen 
the ECG and the EOG signals, because despite giving less information of sleep monitoring com-
paratively to the EEG, are less complex to analyse, ensuring that it is possible to do the devel-
opment of the hardware and the signals analysis in the time agreed.  The oxygen saturation 
was also a variable selected since it can detect sleep respiratory disorders. The actigraphy is 
the most common parameter used in sleep commercial wearable devices and since actigraphy 
and temperature are included in the VitalJacket® technology it will also be considered in the 
VitalSleep system.  After chosen the physiological parameters, it was study what kind of wear-
able device could incorporate all these variables, ensuring that it is comfortable and easy to 
use. It was concluded that a headband could incorporate these sensors and, at the same time, 
is easy to use and comfortable.  
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4.1. VitalSleep System Architecture 
 
VitalSleep system is constituted for the following units: hardware of the prototype wearable 
device that is subdivided in the hardware of Biodevices S.A. board and the hardware of proto-
type board; acquisition platform that enable to visualize, in real-time, the data of physiologic 
variables monitored, save and import data; and the sleep stage processing unit that is subdi-
vided in the pre-processing and analysis of the signals acquired, design of an algorithm to sleep 
staging and posterior evaluation using the MIT-BIH Polysomnographic Database, a database of 
PhysioNet that has a large archive of physiological data, including files with sleep stages anno-
tations. In Figure 4.1.1 it is possible to observe a schematic of the VitalSleep system.  
 
 
 
 
VitalSleep prototype is a headband that incorporate the following sensors: electrooculo-
gram, electrocardiogram, oxygen saturation, actigraphy and temperature. The first VitalSleep 
prototype is presented in Figure 4.1.2.  
 
Figure 4.1.1 - Schematic of the VitalSleep system. 
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Figure 4.1.2 - First prototype of the wearable device developed during the Master Thesis. In this figure 
it is represented the VitalSleep extension board prototype, the main board of Biodevices, S.A., the battery 
and the following sensors: accelerometer, oximeter, temperature, EOG and ECG. 
 
4.2. Hardware Development  
 
The hardware of VitalSystem is constituted by the prototype board and the VitalJacket® 
maian board. To extend the prototype board to the Vital Jacket® main board it was necessary 
to connect the hardware board to Biodevices, S.A board (main board) through the Vital Jacket® 
connector, enabling the use of Biodevices, S.A board microcontroller. So, first it was made an 
electronic prototype board that could connect the VitalJacket® connector in one side of the 
board and a flat cable in the other side to connect with Biodevices, S.A. board. This allows that 
the signals acquired by the prototype board were sent to the main board where the signals from 
the VitalJacket® are also being acquired. 
For the development of the hardware of the prototype board it was necessary to, initially, 
implement the circuit to acquire the horizontal movement of the eyes, since the other sensors 
are already implemented [94]. After the validation of the EOG circuit, the design of the PCB of 
the VitalSleep prototype board using the Altium software was made and tested.  
In the Figure 4.2.1 it is possible to observe a component diagram that represents the inter-
action between the prototype board and the Vital Jacket® main board. 
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VitalSleep prototype board is divided into the Electrooculogram module, the oxygen satu-
ration module and the power management module. Each of these modules will be further dis-
cussed. The Vital Jacket® T-shirt connector and the connector to the Biodevices, S.A main 
board allows the access of ECG, EOG, oxygen saturation, temperature and actigraphy to the 
main board and the SPI communication between the developed schematics modules.  
 
The SPI communication allows a synchronized communication between a master and one or 
more slaves, through Serial Clock (SCK), Master Out Slave In (MOSI), Master In Slave Out (MISO), 
and Slave Select (SS) lines. The SCK channel allows the synchronization of data between the 
master and the slave, and depending on the configuration of the microcontroller, when this 
channel goes high or low, a bit is transferred to the slave; the MOSI channel allows the trans-
mission of data from the master to the slave; the MISO channel allows the transmission of data 
from the slave to the master; and the SS channel is unique for each slave and selects which 
slave will be in communication with the master.  
 
In Figure 4.2.2 it is presented the schematic representation of the develop prototype hard-
ware architecture and the SPI communication between schematic modules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1 - Component diagram of VitalSleep prototype. 
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In the following sub-chapters, it will be described the electronic circuits schematics of the 
VitalSleep prototype. 
 
4.2.1. Electrooculogram Module 
 
The EOG signal has a range of frequency between 0.1 Hz to 20 Hz and a range of amplitude 
between 50 µV to 3500 µV [24]. 
 The ADC of the Biodevices, S.A. board has a sampling frequency of 500 Hz, a resolution of 
8 bits and a range of -3.3 mV to 3.3 mV.  
Since the potential difference of horizontal eye movements is very small, it was used an 
AD620 instrumentation amplifier to amplify this small amplitude. The AD620 was chosen be-
cause is a monolithic instrumentation amplifier based on a modification of three op amp ap-
proach, is easy to use, has a gain range of 1 to 10 000, has a wide power supply range (± 2.3 V 
to ± 18 V), higher performance than 3 op-amp approach, low noise and higher CMRR [95]. 
To have an input signal in the range of the EOG signal and taking into account the baseline 
fluctuations, it was used a gain of 494. The AD620 requires an external resistance, RG, to define 
the gain. The expression of the gain, G, is given by Eq. (5.1), 
 
Figure 4.2.2 - Schematic of the VitalSleep prototype board, which are divided into the Electrooculogram 
module, the AFE4400 module, the power management module, the VitalJacket® connector and the con-
nector of the Biodevices, S.A. main board, and the SPI communication between them. 
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G= 
49.4 kΩ
RG
+1  , (5.1) 
 
where RG has a value of 100Ω. 
During the amplification of the signal, the output voltage of the amplifier can be amplified 
with noise in the range of 49 Hz to 51 Hz. In addition, this signal can be easily contaminated 
with electrodes artefacts, power line noise and muscle movements artefacts [96]. In order to 
remove this noise and considering the frequency of interest to analyse the EOG signal during 
sleep, a low pass RC filter with a cut-off frequency of 4.82 Hz was applied. The general expres-
sion of the cut-off frequency of the low pass filter, Fc, is given by Eq. (5.2), 
 
 
Fc= 
1
2πRC
  , (5.2) 
 
where R corresponds to the resistance and C to the capacitor. 
 The Figure 4.2.3 shows the schematic of the Electrooculogram module.  
  
 
Regarding the placement of the electrodes, it was used three electrodes to monitor eye 
movements: one is placed 1 cm above the outer corner of the right eye, the other is placed 1 
cm below the outer corner of the left eye, and the reference electrode is placed 1 cm above 
the bridge of the nose. This arrangement of the electrodes was suggested by Rechtschaffen and 
Kales [96]. 
To validate this circuit, it was built in a breadboard – Figure 4.2.4. The sensors were placed 
as already mentioned. It was verified that if the electrode connected to the pin 3 (+IN) of the 
AD620 was placed in the outer corner of the left eye, when the person looked to the right side, 
a negative peak appeared in the wave of the signal and when looked to the left side it appeared 
a positive peak in the signal wave. The Figure 4.2.5 shows these results. 
 
 
 
 
 
Figure 4.2.3 - Schematic of the Electrooculogram Module. 
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Figure 4.2.4 - EOG circuit implemented on a breadboard for monitoring horizontal eye movement. In this 
circuit three electrodes are used: one (rede) is placed 1 cm above the outer corner of the right side of one 
eye, the other (red) is placed 1 cm below the outer corner of the left side of the other eye and the reference 
electrode (yellow) is placed 1 cm above the bridge of the nose. 
Figure 4.2.5 - Monitoring of horizontal eye movements through the implemented EOG circuit on a bread-
board. If the electrode connected to the pin 3 (+IN) of the AD620 was placed in the outer corner of the left 
eye, when the person looked to the right side, a negative peak appeared on the signal - left image. When 
the person looked to the left side, a positive peak appeared on the signal - image on the right. 
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After the validation of the EOG circuit, the schematic of the Electrooculogram module was 
design in Altium software. In this schematic was used a connector for the three electrodes that 
capture the signal of the horizontal movement of the eyes. 
 
 
4.2.2. Oxygen Saturation Module 
 
This module allows the acquisition of oxygen saturation signal. For the oxygen saturation 
sensor, it was used an Analog Front-End (AFE), AFE4400, developed by Texas Instruments. It 
was chose this type of AFE since it was specially designed to pulse oximetry and allows to 
convert analogue readings into a digital output according to the master-slave communication 
protocol, Serial Port Interface (SPI) [97]. 
 
The AFE4400 has several routes: Transmit Route (TX), Receive Route (RX) and SPI route 
communication. Both TX and RX have two routes: a cathode route to connect to the oxygen 
oximeter sensor LED and an anode route to connect to the photodiode [97]. 
The AFE turns on the LED in the oximeter sensor using the TX route and then turns off the 
LED and collects the received intensities in the photodiode sensor using the RX route to convert 
the analog input to digital using the ADC converter. This process is made four times: twice for 
the determination of the oxygen saturation which requires the sample of the red-light wave-
length and the sample of the infrared light wavelength, and the others two times to acquire 
the ambient light with a more accurate result. Figure 4.2.6 shows when each step of each cycle 
starts and ends. When a complete reading cycle is made, and the digital output is ready to be 
read, the ADC ready pin (ADC_RDY) gets high during a short period of time and then turns low. 
The AFE4400 can subtract the ambient light sample to the corresponding LED value, this occurs 
in the last ADC conversion, and can be read in the SPI output [97]. 
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One of the main features of the AFE4400 is the possibility to program the timings of when 
each action occurs. These timings have a common reference time that is also programmable 
and is directly correlated to an external crystal clock of 8 MHz in the clock route. The AFE4400 
acquire the oscillation of the crystal and convert it to a 4 MHz frequency that is used as AFE 
pacemaker. 
Figure 4.2.6 - Representation of the sampling cycles of AFE4400. In this figure it is possible to observe 
two complete cycles of acquisition and ADC conversion (taken from [97]). 
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Furthermore, two connectors were design in the PCB (one for the emitter sensor and the 
other for the detector sensor) to allow the communication between the oxygen saturation sen-
sor and the prototype board. 
The schematic of this module is present in the Figure 4.2.7 and was based on the recom-
mended circuit in the datasheet of the AFE4400 Texas Instruments [97]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.3. Power Management Module 
 
The AFE4400 has three types of supplies: the RX supplies, which can be between 2.0 V to 
3.6 V; the TX supplies, which can be between 3.0 V to 5.25 V; and the LEDs supplies, which can 
also be between 3.0 V to 5.25 V. In order to simplify the AFE4400 power supply and according 
to the recommendations by Texas Instruments, [97] the voltage used in TX route is the same 
used in LEDs. Thus, the AFE4400 power supply has only two different voltages. The power man-
agement is represented in Figure 4.2.8 and is based on the recommendations by Texas Instru-
ments [98]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.7 - Schematic of the oxygen saturation module based on the recommended circuit by the Texas 
Instruments [79]. 
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4.2.4. Printed Circuit Board Design 
 
After design all the schematics needed for the prototype board, it was possible to design 
the PCB of VitalSleep prototype board, using the software Altium, the same software used for 
schematics design. To make the PCB, it was necessary to design the specific footprint of each 
component, which consists in drawing the pads of the components that will be soldered to the 
board. Finally, to create a 3D representation of the board, it was necessary to associate the 
corresponding 3D model of the component to each footprint. These 3D models were imported 
from the 3D ContentCentral page, an OpenSource. 
  In this PCB two layers were used: top and bottom – Figure 4.2.9. It is noteworthy that to 
make the prototype more comfortable, one of the requirements was to make it small. The final 
size was 33 mm x 40 mm. 
 
 
Figure 4.2.8 - Schematic of the power management module based on the recommended circuit by 
the Texas Instruments [79]. 
Figure 4.2.9 - PCB design of VitalSleep prototype board. Top layer (left image) and bottom layer (right image). 
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In Figure 4.2.10 it is possible to observe the 3D model of VitalSleep prototype board. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.5. Prototype Extension Assembly  
 
The production of the PCB is the next step. For this, it was necessary to generate Gerber 
files with the design of the layers and with the drills that are necessary to make in the PCB 
fabrication. To verify if the PCB is exactly as it was designed, a Gerber design generated by the 
producer was verified. After this process some errors were detected, such as a bad union be-
tween vias and/or between a via and a route. These errors were corrected, and the process 
was repeated until agreed with the design of the PCB. Finally, the PCB was ordered to be 
produced and the components needed were purchased. In Figure 4.2.11 it is possible to observe 
the produced PCB of the VitalSleep prototype.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.10 - 3D model of VitalSleep extension board prototype. The left image shows the top view 
and the right one shows the bottom view. 
Figure 4.2.11 - Top layer (left image) and bottom layer (right image) of the produced PCB of the Vi-
talSleep prototype board with the identified modules and connectors. 
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When all the components and the PCB were received, is was necessary to learn how to 
solder the components to the board. After the prototype board assembly It was necessary to 
test the board, more specifically, the ECG, EOG, oxygen saturation and temperature signal.  
Regarding the oxygen saturation test, the AFE4400 power supply was evaluated. The values 
of the TX and RX roots supply were measured, 5,34 V and 1,36 V, respectively. It was verified 
that the measured value of the TX route was within the range of expected values of the power 
management circuit developed however the measured value of the RX route was significantly 
lower than the range of expected values. After some experiments and resoldering the value of 
the RX route it was not still in the range of expected values, maybe due to some components’ 
failure. After all tries and taking into account the time to developed the rest of the work that 
includes the test of the other signals, the acquisition of sleep recording using VitalSleep proto-
type, signal analysis, the design of the algorithm to sleep staging and posterior evaluation using 
the PhysioNet Database, it was decided to continue the VitalSleep prototype development with-
out considering the oxygen saturation sensor.  
For the EOG signal test, it was verified if the voltage was corrected: 3.3 V and -3.3 V, and 
for the ECG and temperature signal test, it was verified the conductivity between the ECG 
electrode cables and the prototype board and between the temperature sensor and the proto-
type board, respectively. 
 
The next and last step of the hardware development was the incorporation of the EOG 
electrode cables in the prototype board and the connection between the prototype board and 
the Biodevices. S, A. board. That is described in the next sub-section.  
 
4.2.6. Wearable Prototype Assembly  
 
 The last step of the hardware development was the incorporation of three electrode cables 
for the monitoring of the movement of the eyes. For this, some tests were done to understand 
the best way to incorporate them considering that they would have to be soldered to the PCB. 
Two attempts were used: soldering the filament and the mesh or soldering only the filament, 
dispensing the mesh. It was found that soldering only the filament had less interference. Then, 
heat shrink sleeve was used to make the cables more stable and less sensitive to external in-
terference. To finalize, the connection between the VitalSleep prototype and the main board 
was made through a flat, as it can be seen in the Figure 4.2.12. 
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First acquisitions showed some problems in the EOG signal that could derive from electrodes 
gel or electrode cables. Acquisitions with different types of gel electrodes were made and the 
differences were almost insignificant. The second alternative was to change electrode cables 
to gold electrode cables and insulate them with heat shrink sleeve – Figure 4.2.13. This solution 
had more significant improvements, however, the best solution would be to have connectors 
on the PCB to connect electrode cables without the need to strip and solder them to the board.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
´ 
Figure 4.2.12 - Connection between the VitalSleep prototype board and the main board and the incor-
poration of the EOG and ECG electrode cables and the temperature sensor. 
Figure 4.2.13 - Incorporation of gold electrode cables. 
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The Figure 4.2.14 shows the VitalSleep prototype with the electrode cables, the VitalSleep 
prototype board and the Biodevices, S.A. main board incorporated in the headband. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3. Firmware Development 
 
The development of the firmware was made using a software named MPLAB X IDE. With this 
software it is possible to implement through C programming language the firmware for a spe-
cific Microchip microcontroller such the one that is used in the main board, which cannot be 
specified because it is Biodevices. S, A. property. The MPLAB X IDE has a plug-in tool named 
MPLAB Code Configurator that allows to generate automatically the code for the initialization 
and control of the microcontroller pins, more specifically, allows to select and setup the pe-
ripherals, to select the pins of the microcontroller, to set up the input/output pin configura-
tions and to select their functions. After these configurations, the MPLAB Code Configurator 
create a peripheral driver code with functions automatically developed for each peripheral that 
is open sourced and editable [99]. Figure 4.3.1 shows a window of MPLAB Code Configurator. 
 
 
Figure 4.2.14- VitalSleep Prototype. Incorporation of electrode cables, VitalSleep prototype board and 
Biodevices, S.A. main board in the headband. 
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After generating the code using the MPLAB Code Configuration it was made the remaining 
code for the oxygen saturation sensor, electrooculogram sensor and for the SPI communication 
to allow to send and receive bits from a selected slave. The microcontroller used in this work 
has an 8-bit architecture, so the communication is in groups of 8-bit. These groups of 8-bits are 
named as register and can contain until 8 bits to identify what is the address of the respective 
register, the remain bits contains the information about that register. As example, to define 
some setting in a slave it is necessary to send the address of the register that contain the 
wanted setting and then it is necessary to set high or low bits according to the specification. 
The datasheets of the components have a list of the registers and the respective description 
relatively to the address and the setting that each bit defines.  
 
For the development of the AFE4400 firmware it is first necessary to initialize the slave 
pins. Then it is necessary to initialize the AFE4400, which consist in the following steps: reset 
of all registers; check if the AFE4400 has any fault, returning a certain number of bits to inform 
its status; send twenty seven timing control registers to set when each operation starts and 
ends; and send five register related to the AFE4400 operation mode to define crucial configu-
rations.  
After the reset and initialization, it is necessary to implement the reading and writing func-
tions to allow the communication between the microcontroller and the AFE4400. Each register 
of the AFE4400 has 32 bits where the first 8 bits indicate the address of the register that is 
being sent and the remaining 24 bits corresponds to the information about that register. Taking 
this into account, for the writing process in AFE4400 the microcontroller sends 32 bits, divided 
in groups of 8 bits. For the reading process, the AFE4400 must be set in the reading mode by 
sending a specific register with a bit to active the reading mode. When the reading mode is 
active it only can be turned off if the same register is sent with the opposite value of the same 
bit. In this case, the reading mode is inactivated, and the writing mode is activated. To get a 
register from AFE4400, the reading mode must be active, and it is necessary to send the 8 bits 
that contains the register address that is going to be read. After receiving the register address, 
Figure 4.3.1 – Window of MPLAB Code Configurator 
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the AFE4400 writes the information of the requested register in the next 24 clock cycles. That 
information is read and saved.       
 
Due to the hardware problem of the oxygen saturation module as mentioned in the sub-
section “4.2.5 Prototype Extension Assembly”, it was not possible to progress with the AFE4400 
firmware. The next step would be read the oxygen saturation sensor values.   
 
For the EOG firmware it was necessary to initialize the selected pin and to do an ADC 
conversion.  
After this the firmware was integrated in the Biodevices. S.A VitalJacket® firmware. 
 
A first acquisition of EOG, ECG, temperature and actigraphy signals was made to verify if 
they were being acquired correctly. The visualization of these signals in real time was made 
through an application of Biodevices, S.A. that contains the EOG signal, besides the variables 
already implemented by Biodevices, S.A. technology. 
 
The next steps were the analysis of the variables in MATLAB, including the pre-processing 
of the signals and the extraction of essential characteristics for sleep staging, the design of the 
algorithm for sleep staging and the evaluation of the algorithm using the PhysioNet Database, 
as it will be described in detail in the next section. 
 
4.4. Sleep Stage Processing Unit 
 
In this section it will be presented the signal analysis made for the four variables imple-
mented in the VitalSleep prototype – electrocardiogram, electrooculogram, temperature and 
accelerometer. The algorithm designed for sleep staging was also be described. 
In order to evaluate the algorithm developed, the results of the algorithm will be evaluated 
using the MIT-BIH Polysomnographic Database, a database of PhysioNet, [100] that contains 
polysomnographic exams classified by a specialist in the different stages of sleep: 
wake/REM/deep sleep/light sleep. The variables that are monitored in these exams are EEG, 
EOG, respiration, oxygen saturation and EMG. So, neither the temperature nor the body move-
ments - variables included in the VitalSleep prototype - were monitored in these exams.  
Different algorithms will be design, implemented and evaluated using the PhysioNet Data-
base: one algorithm only based on the ECG variables, other only based on the EOG variables 
and another based on the combination between the ECG and EOG variables. For the tempera-
ture and actigraphy signals, the algorithms were not evaluated because the PhysioNet Database 
do not have these signals.  
 
4.4.1. PhysioNet Database 
 
PhysioNet is a research resource that provides free web access to a large number of rec-
orded physiological signal and is subdivided in three components: PhysioBank that contains a 
large number of recording physiological data; PhysioToolkit that has a large library of software 
that allows, for example, signal processing and analysis; and PhysioNetWorks for members of 
PhysioNet that allows the development of data and software resources that can be incorporated 
in PhysioBank and PhysioToolkit [100]–[102].  
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Regarding the PhysioBank it contains about 90 000 recordings organized in 80 databases – 
over 4 terabytes of physiological signals. The database used to evaluate the developed algo-
rithms was the MIT-BIH Polysomnographic Database that has recordings of multiple physiological 
signals during sleep. This database includes 18 records of subjects that were monitored in Bos-
ton’s Beth Israel Hospital Sleep Laboratory. All recordings include an ECG signal, an EEG signal, 
a respiration signal and an invasive blood pressure signal, and are annotated with respect to 
sleep stages and apnea, if it was the case. The recordings with six and seven channels, include 
a respiratory effort signal, some include an EOG and an EMG signals, and the remaining record-
ings include a cardiac stroke volume signal and an earlobe oximeter signal [100], [102].   
Only 2 of the 18 recordings were recorded from subjects without sleep disorders, and both 
recordings include EOG and ECG signals but not include temperature and actigraphy signals. 
For this reason, only the algorithm design based on the ECG and EOG variables can be evaluated 
using the MIT-BIH Polysomnographic Database [100], [102].   
 
4.4.2. Electrocardiogram Analysis 
 
The heart rate variability (HRV) is an important parameter that can be extracted from the 
ECG signal. It allows to evaluate the autonomic nervous state through the variations between 
consecutive heartbeats and has a frequency and time domain. Through the variations of the 
frequency and time domain variables it is possible to perform a sleep staging, as described in 
the sub-section “2.4.4. Electrocardiogram”.  
 
The HRV is obtained from ECG signal and can be derived from intervals between consecutive 
R peaks. It is important to enhance that all RR intervals were named normal-to-normal (NN) 
intervals because the acquisition of the ECG signal was made during a rest position – sleep – 
and has a good quality has it can be observed in Figure 4.4.1.  
The NN intervals were extracted through the QRS wave using the Pan Tompkins implemen-
tation. This implementation will be explained in this sub-section and is also represented in the 
workflow of the Figure 4.4.2 [103].  
The first part of the Pan Tompkins algorithm consists in the preprocessing of the signal. 
More specifically, the signal can be influenced by many types of noise, such as, power-line 
interference. To reduce this noise, it is implemented a bandpass filter with 5-15 Hz – frequency 
band to maximize the QRS energy. Then it is used a derivative filter to provide the information 
about the QRS complex slope and the signal is squared to enhance the dominant peaks and to 
restrict false positives caused by T waves which have higher spectral energy than normal. A 
moving window integrator is applied to smooth close-by peaks [103]. 
After the preprocessing of the signal it is necessary to do some decision rules to correctly 
detect QRS complex. In an initial phase the threshold of the signal and the noise peaks are 
detected. Then two heartbeats indicate the average of the NN interval and NN interval limit. 
It is necessary to highlight that the thresholds are adjusted periodically to adapt the charac-
teristics of the signal. This algorithm uses two threshold values to classify each peak as either 
signal or noise: if the sample is higher than the threshold of the signal then it is identified a 
possible QRS complex; if the sample is higher than the threshold of the noise and less than the 
signal threshold then it is considered a noise peak. In addition, this algorithm does not accept 
QRS complexes that occurred within 200 ms after a previously detected QRS complex. If the 
possible QRS complex occurs after the 200 ms but within 360 ms of the previous QRS complex, 
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the algorithm detects if it is a possible QRS complex or if it is an abnormal T wave, through the 
mean slope of the waveform at that position: if the slope is less than one half of the previous 
QRS complex then it is a T wave [103]. In Figure 4.3.2 are shown the described steps of the 
Pan-Tompkins algorithm implemented on the ECG signal.   
After the detection of all QRS complex, the NN intervals between successive heartbeats 
were determined to characterize the HRV. The analysis of the HRV can be divided into time-
domain or frequency-domain [28]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1 - Implementation of the Pan-Tompkins algorithm. In this figure it is possible to observe a segment 
of an ECG signal without any pre-processing (superior image), subject to a bandpass filter (middle image on 
the left side), subject to a derivative filter (middle image on the right side), subject to a squared signal (lower 
left corner image), and, finally, the detection of the QRS complex (lower right corner image). The black line 
represents the noise, the green line represents the adaptive threshold, the red line represents the signal level 
and the pink circles represent the QRS adaptive threshold. 
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4.4.2.1. HRV - Time Domain Method 
 
The time domain method is one of the simplest methods to measure heart rate variations 
through the intervals between successive normal QRS complexes.  
According to [28] and a study by Jiang et al., [29] the most common variables that can be 
calculated and used to described the sleep stages are the mean NN interval, which is the inter-
val between successive QRS complexes and the standard deviation of the NN interval (SDNN). 
The SDNN is calculated through the square root of variance so it reflects the cyclic components 
responsible for the variability. The SDNN is relatively insensitive to small errors, although is not 
a well-defined statistical variable, since it depends on the length of the registration period. 
Thus, in order to compare SDNN measurements of several records, their duration should be 
standardized [28]. In Figure 4.4.3 are represented the different variables measured using the 
time domain method: NN intervals, mean NN intervals and SDNN.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.2 - Workflow of the implementation of the Pan-Tompkins algorithm [103]. 
 
Figure 4.4.3 - Time domain variables: NN intervals (s), mean NN intervals (s) and SDNN (s). 
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4.4.2.2. HRV - Frequency Domain Method 
 
The spectral analysis of the NN intervals is often used to evaluate the cardiac system during 
sleep since the spectral power in specific band frequencies is related to the activity of the 
sympathetic and parasympathetic nervous system, more specifically, the spectral power in high 
frequency (0.15-0.4 Hz) and the spectral power in low frequency (0.04-0.15 Hz) are associated 
with the activity of the parasympathetic nervous system and the activity of the sympathetic 
and parasympathetic nervous system, respectively. [34], [104] Studies have shown, through this 
type of analysis, that the parasympathetic tone is higher during sleep than during the awake 
state, being higher in the NREM phase compared to the REM phase and also showed that there 
is a small decrease in the sympathetic tone from awake state to NREM phase and an increase 
during REM phase.[105], [106]. 
The method chosen for spectral analysis was the power spectral density (PSD) as it provides 
basic information on how power is distributed as a function of frequency. Standard methods for 
estimating PSD include Fourier Transform and autoregressive methods (AR) that operate in time 
series with uniform intervals between samples. Thus, to apply one of these methods to the time 
series of heart rate, it is necessary that these series be resampled at uniform intervals. This 
process can attenuate the high frequency components. Furthermore, if there are discontinuities 
in the series of NN intervals, due to, for example, the presence of ectopic beats and noise, 
these methods require the discard of these data, which leads to the possibility of introducing 
bias in the HRV analysis, or the replacement of these data by estimating probably values, which 
may lead to a change in frequency content. For these reasons, the method chosen to calculate 
the spectral frequency domain was the Lomb-Periodogram, since it does not require resample 
or sample replacement. [107] 
 For the spectral analysis, it was first necessary to extract the heart rate from the ECG 
signal (methodology already explained in subsection “4.4.2 Electrocardiogram Analysis”). Then, 
the Lomb-Periodogram method was applied. Using this method, it is possible to calculate the 
two main frequency components that are associated with autonomic nervous system activity: 
low frequency, LF (0.04-0.15 Hz), and high frequency, HF (0.15-0.4 Hz). Finally, the power 
average was calculated for every 5 minutes of the LF component and the HF component. This 
measurement is usually made in absolute values of power (ms2) and then transformed into 
logarithmic values [28], [108] The choice of 5-minute intervals is due to the fact that frequency 
domain analysis requires stationarity, that is, it requires that the mean and variance of the 
signal do not change significantly at different stages of recording. In this way the choice of a 
short period of time tends to satisfy this condition. The ratio of LF/HF was also calculated every 
5 minutes as it is often used to assess changes in autonomic function between sleep stages 
[109]. In Figure 4.4.4 are represented the different variables measured using the frequency 
domain method: HF, ratio LF/HF and the Lomb-Periodogram of all signal. 
A study by Versace et al showed that the mean HR is higher in the REM phase than in the 
NREM phase. It also showed that the LF is slightly higher in the REM phase compared to the 
NREM phase, contrary to the HF that is higher in the NREM phase than in the REM phase, how-
ever, this latter difference decreases over the cycles [34]. 
 
 
 
72 
VitalSleep: A wearable sleep system 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4.2.3. Development of Sleep Staging Algorithm based on Frequency and 
Time Domain Variables of the HRV   
 
To perform a sleep staging based on frequency and time domain variables of the heart rate 
variability, it was necessary to understand which variables predominate in each phase of sleep.  
In early studies it was proposed that the autonomic nervous system has related to the sleep 
and that sleep stages were related with changes in this system: the REM phase is associated 
with an increase of sympathetic activity and the NREM phase is associated with an progressive 
increase of parasympathetic activity (from stage 1 to stage 4) [110].   
As already described in the subsection “2.4.4 Electrocardiogram”, for the variation of time 
domain variables, studies showed that the mean NN interval was lower during wake time than 
during sleep time and was greater during deep sleep than during REM sleep.  The SDNN is higher 
during wake time than during sleep time, and deep sleep has lower values compared to other 
sleep phases [30]–[33]. For the variation of frequency domain variables, studies showed a higher 
LF component during the REM phase compared to the NREM phase, and in this last phase the LF 
component is lower in the deep sleep. The HF component is lower during wake time than during 
Figure 4.4.4 - Frequency domain variables: LF, HF, ratio LF/HF and the Lomb-Periodogram of all sig-
nal. The red colour represents the low frequency and the green one represents the high frequency. 
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sleep time, being higher during NREM sleep (light sleep) than during REM sleep. The ratio be-
tween low frequency and high frequency is higher during REM sleep than during wake time and 
is lower during deep sleep [31], [33], [35]. 
Considering the predominance of different variables in different stages of sleep, an algo-
rithm was developed in MATLAB, based on the method implemented by Kesper et al. [111]. 
Figure 4.4.5 represents the workflow of the developed algorithm.  
Initially, the signal was classified as light sleep since during the night about 50% of sleep is 
light sleep. Then the frequency domain variables classified sleep phases into Wake/REM/deep 
sleep. For the HF and LF components, the difference between the maximum value and the 
minimum value of the respective component was first calculated and divided by 4, since these 
two components can differentiate the WAKE, REM sleep, light sleep and deep sleep. These 
values will be called ‘a’ and ‘b’, respectively. For the ratio between LF and HF, the difference 
between the maximum value and the minimum value was calculated and divided by 3, since 
this ratio can differentiate the WAKE, REM sleep and deep sleep. This value will be called ‘c’. 
Taking this into account, it is considered REM phase if it reunited the following conditions: the 
HF component has a value superior to the sum between the minimum value of HF component 
and 50 % of the ‘a’ value  but inferior to the sum between the minimum value of HF component 
and 70 % of the ‘a’ value; the LF component is higher than the sum between the minimum value 
of LF component and 75 % of the ‘b’ value; and the ratio LF/HF is higher than the sum between 
the minimum value of the ratio LF/HF and 66 % of the ‘c’ value. It is considered Deep sleep if: 
the value of the HF component is higher than the sum between the minimum HF component 
and 25 % of the ‘a’ value but inferior to the sum between the minimum HF component and 50 
% of the ‘a’ value; and if the value of the LF component is inferior to the sum between the 
minimum LF component and 25 % of the ‘b’ value and if the value of the ratio LF/HF is inferior 
to the sum between the minimum LF/HF and 33 % of the ‘c’ value. It is considered Wake if the 
value of the HF component if inferior to the sum between the minimum HF component and 25 
% of the ‘a’ value; if the value of the LF component is superior to the sum between the minimum 
LF component and 50 % of the ‘b’ value and 75 % of the ‘b’ value, and if the value of the LF/HF 
ratio is superior to the sum between the minimum LF/HF value and 33 % of the ‘c’ value and 
inferior to the sum between the minimum LF/HF value and 66 % of the ‘c’ value. Then, the 
segments classified as REM sleep were verified through the NN intervals, since this time domain 
variable presents large variations of NN intervals during the final period of REM sleep [112]. So, 
if the REM sleep corresponds to the time when one of the 6 maximum differences between the 
maximum and the minimum NN interval occurs, then it is considered REM phase, if not it is 
considered Light Sleep. It was calculated the 6 maximum differences between the maximum 
and the minimum NN interval because it was considered that during a normal night occur six 
REM phases – one REM phase per sleep cycle [9]. This variable was also calculated during 5 
minutes.      
SDNN and mean NN intervals were used to reclassify the light sleep segments in wake time, 
since the values were very different from one another and because in the literature it is refer 
that the differences between the sleep phases are more visible in the spectral analysis [113]. 
So it was considered that during the first 5 minutes, the values would be the basis to consider 
the signal classification in wake time. 
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After the development of the sleep staging algorithm based on frequency and time domain 
variables of the HRV it was necessary to evaluate it. For that, it was used the PhysioNet Data-
base that provides the NN intervals and the annotations of the respective sleep staging. The 
algorithm was then evaluated using the NN intervals of two exams provided by PhysioNet, as 
already mentioned in subsection “4.4.1 PhysioNet Database”. The results of sleep staging were 
compared to the sleep staging annotations of the Database. This evaluation can be seen in 
Figure 4.4.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.5 – Workflow of the developed sleep staging algorithm based on the frequency and time domain 
variables of the HRV 
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The sensitivity, specificity and accuracy were calculated for the different phases of sleep 
of both exams -Table 4.4.1 
 
Table 4.4.1 - Sensitivity, Specificity and Accuracy of the developed algorithm based on ECG variables 
for sleep staging 
 
  Wake Light Sleep Deep Sleep REM 
 
 
Exam 1 
Sensitivity (%) 38,3 88,0 33,7 38,7 
Specificity (%) 92,0 41,3 99,1 94,3 
Accuracy (%) 84,9 67,2 90,3 88,5 
 
 
Exam 2 
Sensitivity (%) 6,1 64,2 16,7 54,5 
Specificity (%) 77,1 27,1 95,0 97,2 
Accuracy (%) 57,3 49,0 93,8 92,2 
Figure 4.4.6 – Evaluation of the developed sleep staging algorithm. The sleep staging based using the 
developed algorithm (discontinuous red line) and the sleep staging provided by PhysioNet Database (green 
line) – (A) Exam 1 and (B) Exam 2. 
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Analyzing the Table 4.4.1 it is possible to observe that the algorithm can easier detect the 
light sleep and the REM sleep comparatively to wake and deep sleep. Regarding the fact that 
the algorithm detects light sleep more easily compared to the other variables, it may be be-
cause in the implemented methodology it was considered initially that the whole signal is light 
sleep since light sleep occurs in more than 50% of one night sleep. Regarding the detection of 
REM phase, the fact that a high variability in heart rate occurs in the final or after the REM, is 
a good indicator for this phase, however, it is not defined in the literature the exact time of 
the REM phase when occurs higher variability. The low percentage of wake time sensitivity may 
be because the time domain variables have a very large range of values, being difficult to define 
the average of each variable in different phases.  
It should be noted that to calculate the spectral analysis, an average of the frequency 
domain variables was made every 5 minutes. This requires that each phase has at least 5 
minutes, and analyzing the signals provided by PhysioNet Database, it is verified that there are 
phases with a duration shorter than this time. 
It should also be referred that after the analysis of the results some readjustments of the 
variables was made in order to have better results, namely, for the classification of the REM 
phase using the variable NN intervals, since, as it was already mentioned, it is not defined the 
exact time of the REM phase when occurs higher variability.   
 
4.4.3. Electrooculogram Analysis 
 
The EOG signal has a range of frequency between 0.1 Hz to 20 Hz and a range of amplitude 
between 50 µV to 3500 µV [25]. As already described in subsection “2.4.2 Electrooculogram”, 
rapid eye movements (> 0.6 Hz) are present during wakefulness and REM phase and are char-
acterized by being irregular, with sharp edges and with an initial deflection of less than 500 
milliseconds and slow eye movements (0.25 Hz - 0.6 Hz) are present in N1 phase [23] and are 
characterized by being regular, with sinusoidal contours and with an initial deflection greater 
than 500 milliseconds [22]. 
Considering the characteristics of rapid eye movements and slow eye movements, the fre-
quency of eye movement and the duration of the sharpest slope of peaks were extracted from 
the EOG signal and used to design the sleep staging algorithm that will be described in the next 
sub-subsection.  
 
Initially, the EOG signal was preprocessed through a low pass filter with a cut-off frequency 
of 15 Hz to eliminate high-frequency and through a high pass filter with a cutoff frequency of 
0.3 Hz to eliminate low-frequency noise from the amplified signal [114]. In Figure 4.4.7 is rep-
resented the EOG signal without and with pre-processing.  
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To calculate the duration of the sharpest slope of the peaks, it was necessary to detect the 
maximum peaks of the signal and to subtract by the closest zero. The mean sharpest slope 
duration was then calculated in periods of 1 minute [115]. The maximum peaks were detected 
using the findpeaks function. In this function it was define that the maximum peaks must have 
an amplitude superior to 0.05 mV and a distance to each other more than 5 seconds, according 
to the maximum duration of SEM. The frequency of eye movement was calculated in periods of 
1 minute [115], using the Fourier Transform. In Figure 4.4.8 it is possible to observe the detec-
tion of the maximum peaks, the mean sharpest slope duration and the frequency of the move-
ments of the eyes both in periods of 1 minute. 
 
 
 
 
 
Figure 4.4.7 - (A) Example of one EOG signal extracted from the Physionet Database without pre-
processing (original signal) and (B) one segment of the EOG without pre-processing. (C) EOG signal pre-
processed (signal filtered) and (D) one segment of EOG signal with pre-processing. 
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4.4.3.1. Development of Sleep Staging Algorithm based on EOG variables 
 
With the two variables describe above, according to the literature it is possible to differ-
entiate wake/REM sleep from NREM sleep, since NREM phase is characterized to do not have 
any ocular movements, except for phase 1 of NREM (light sleep), which is characterized by slow 
eyes movements: the frequency of the slow eyes movements is between 0.25 Hz and 0.6 Hz 
and the sharpest slope of each movement has a duration more than 500 ms [101]. Wake and 
REM phase are characterized with a frequency of eye movements higher than 0.6 Hz and the 
sharpest slope of each movement has a duration less than 500 ms [22]. Figure 4.4.9 represents 
the workflow for the development of this sleep staging algorithm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) 
(C) 
(B) 
Figure 4.4.8 - (A) Example of the detection of the maximum peaks in a segment of the EOG signal, the 
maximum peaks are represented with a red triangle. (B) The mean sharpest slope duration in periods of 
1 minute and (C) the frequency of the movements of the eyes also in periods of 1 minute. 
Figure 4.4.9 – Workflow of the sleep staging algorithm based on the EOG variables 
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For the evaluation of this algorithm, the EOG signal from both exams were extracted from 
the PhysioNet Database. It is important to refer that they only provide 1 hour of EOG signal 
record.  
In Figure 4.4.10 it is represented the evaluation of the sleep staging algorithm based on the 
two variables of the EOG signal for the Exam 1(A) and for the Exam 2 (B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysing the Figure 4.4.10 it is possible to observe that the developed algorithm does not 
have good results compared to the sleep staging provided by PhysioNet Database. A possible 
reason for this is because the determination of the duration of the sharpest slope is not very 
rigorous, since for this calculation, the maximum peak of the ocular movements is subtracted 
from the nearest zero. Due to that, in the algorithm it will not be considered this characteristic 
of the EOG signal and it only be considered the frequency of eye movement. The Figure 4.4.11 
represents the evaluation of the new sleep staging algorithm based only on the frequency of 
eye movement for the Exam 1(A) and for the Exam 2 (B).  
Figure 4.4.10 – Evaluation of the sleep staging algorithm based on the frequency of eye movements and 
based on the duration of the sharpest slope, using the Exam 1 (A) and Exam 2 (B) provide from PhysioNet 
Database. The sleep staging based on the developed algorithm is represented with a discontinuous red 
line and the sleep staging provided by PhysioNet Database is represented with a continuous green line.  
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Figure 4.4.11 - Evaluation of the sleep staging algorithm only based on the frequency of eye movements, 
using the Exam 1 (A) and Exam 2 (B) provide from PhysioNet Database. The sleep staging based on the 
developed algorithm is represented with a discontinuous red line and the sleep staging provided by Physio-
Net Database is represented with a continuous green line. 
 
The sensitivity, specificity and accuracy were calculated for the different phases of sleep 
for both exams -Table 4.4.2 
 
 
 
 
 
 
 
 
 
81 
Sleep Stage Processing Unit 
 
 
 
 
Table 4.4.2 - Sensitivity, Specificity and Accuracy of the developed algorithm based on the EOG varia-
bles for sleep staging 
 
 
 
 
 
 
 
 
 
Analyzing the Table 4.4.2 and the Figure 4.3.11 it is possible to verify that the developed 
sleep staging algorithm detect mostly the Wake phase. Although the literature reports that the 
frequency of rapid eye movements is greater than 0.6 Hz and the frequency of slow eye move-
ment ranges from 0.25 Hz to 0.6 Hz [26], [106] , it is possible to verify that the sleep staging 
by taking into account these values are not in agreement with the sleep staging provided by 
the PhysioNet Database. In this way, it was made a readjustment and it was considered that 
the frequency of slow eye movements ranges from 0.25 Hz to 0.62 Hz and the frequency of 
rapid eye movements is greater than 0.62 Hz. So, the frequency of eye movement is a charac-
teristic that should be further studied.  
To make this algorithm more accurate, a possible solution would be the evaluating of other 
characteristics of the signal, such as the determination of the curvature time of REM waves and 
slow eyes movements (SEM) waves, since one of the characteristics that distinguishes them is 
the fact that the REM waves have contours pointed and SEM waves have sinusoidal contours.  
 
4.4.4. Development of Sleep Staging Algorithm based on Electrocardiogram 
Variables and Electrooculogram Variables 
 
To understand if the combination between ECG variables – frequency and time domain var-
iables of the HRV - and the EOG variable – frequency of eye movements - provide better accu-
racy than the last two sleep staging algorithm described in the previous sub-subsections, an 
algorithm was developed based on these variables. In Figure 4.4.12 it is represented the work-
flow of the algorithm developed.  
For the development of this algorithm, it was first considered the sleep staging based on 
the algorithm developed in the sub-subsection "4.4.2.3 Development of Sleep Staging Algorithm 
based on Frequency and Time Domain Variables of the HRV". For segments that were staged as 
light sleep, if the algorithm developed based on the frequency of eye movement detected that 
segment as wake, then it would be considered wake. 
  Wake/REM Light Sleep Deep Sleep 
 
Exam 1 
Sensitivity (%) 100 3,7 0 
Specificity (%) 52,0 100 100 
Accuracy (%) 63,8 60,7 47,0 
 
Exam 2 
Sensitivity (%) 90,6 21,3 0 
Specificity (%) 78,1 90,6 100 
Accuracy (%) 82,3 65,9          100 
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In Figure 4.3.13 it is possible to observe the evaluation of sleep staging algorithm for the 
Exams 1 (A) and 2 (B) provided by PhysioNet Database. The sensitivity, specificity and accuracy 
were calculated for the different phases of sleep of both exams -Table 4.4.3 
 
Figure 4.4.12 – Workflow based on the combination between the ECG variables and the EOG variable 
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Table 4.4.3 - Sensitivity, Specificity and Accuracy of the developed algorithm for sleep staging 
 
  Wake Light Sleep Deep Sleep REM 
 
 
Exam 1 
Sensitivity (%) 45,3 73,4 33,7 38,8 
Specificity (%) 80,1 54,6 99,1 94,5 
Accuracy (%) 74,2 66,4 90,2 88,5 
 
 
Exam 2 
Sensitivity (%) 38,0 57,8 16,7 54,5 
Specificity (%) 71,9 48,6 94,9 97,2 
Accuracy (%) 62,2 53,9 93,8 92,2 
Figure 4.4.13 - (A) Evaluation of sleep staging algorithm using the Exam 1 and (B) of the Exam 2 provide 
by Physionet Database. The sleep staging based on the developed algorithm is represented with a discon-
tinuous red line and the sleep staging provided by PhysioNet Database is represented with a continuous 
green line. 
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Comparing the results of the algorithm developed based on the variables extracted from 
the ECG signal and the variable extracted from the EOG signal, with the results of the other 
two algorithms developed it is possible to observe that the sensitivity of the wake phase is 
better when the EOG variable is added. This shows the importance of monitor EOG signal.  
 
It is important to mention that, during the development of the algorithms, some changes 
were made to improve the accuracy. Since the dataset is small, doing readjustments in the 
algorithms can influence the results. A larger dataset would be needed for a better evaluation 
of the algorithms. 
 
4.4.5. Skin Temperature: Development of Wake/Sleep Staging Algorithm   
 
As already mentioned above, the temperature is a variable that is not included in the 
PhysioNet database. In this way, it was not possible to evaluate it. However, the monitoring of 
this parameter is important because allows to know when the sleep onset occurs, since the skin 
temperature increases, and when the wake time occurs, the skin temperature decreases [48], 
[50].  
To analyze the temperature signal it was necessary to make a signal acquisition using Vital 
Sleep prototype. This acquisition was done under normal ambient temperature conditions and 
during 200 minutes. After 195 minutes the person was awaked by an alarm. Then, the temper-
ature data was extracted from the VJ Holter Reader software from Biodevices, S. A. The tem-
perature is monitored each 1 minute – condition of Biodevices, S.A.  
Based on the literature  [48], [50] it is possible to know when the sleep onset occurred and 
when the wake time occurred. Figure 4.4.14 represents a workflow for the developed algorithm 
based on temperature. 
The sleep onset occurred when the temperature reaches its maximum, so for that it was 
necessary to determine the time when the maximum temperature occurred. Relatively to the 
moments when wake time occurred, it is known that when it happens the temperature de-
crease, although in the literature it is not stated how much the temperature decreases. There-
fore, it was considered that the wake time occurred when the minimum temperature occurred.    
 
 
 
 
Figure 4.4.14 – Workflow of the development of the algorithm based on temperature. 
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In Figure 4.4.15 (A) it is possible to observe the variation of the temperature in a sleep 
recording using VitalSleep prototype and in Figure 4.4.15 (B) it is possible to observe the sleep 
staging – sleep onset and wake time – based on the temperature variations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analyzing the Figure 4.4.15 it is possible to verify that the sleep onset starts around the 
minute 41, which corresponds to the first maximum, and wake time occurs in the last minutes 
of recording which corresponds to the minimum values.  The person who was subjected to this 
monitoring reported that took some time to fall asleep, which may justify the 41 minutes to 
fall asleep. Relatively to the time when wake occurs, it is possible to observe that it corresponds 
near the minute 195, when the alarm clocked. However, with this algorithm it is not possible 
to ensure that do not occurred more wake times, since it was only considered the time of the 
minimum temperature.  
Without a database to evaluate this algorithm, more acquisitions must be made. It is also 
be enhance that the skin temperature depends on the temperature that the body receives, for 
example, through the clothing of the body. So, this variable must also be considered.  
 
4.4.6.  Accelerometer: Development of Wake/Sleep Staging Algorithm 
 
As noted for temperature, accelerometer monitoring is also not covered in the PhysioNet 
Database, so it is not possible to evaluate the algorithm. However the movements of the body 
is a good indicator to detect wake time, since there are more movements in this phase [108]. 
To analyze the actigraphy signal it was necessary to make a signal acquisition using Vital 
Sleep prototype. This acquisition was done at the same time when the temperature was ac-
quired, so was done under normal ambient temperature conditions and for 200 minutes. After 
195 minutes, the person was awaked by an alarm. Then, the actigraphy data was extracted 
from the VJ Holter Reader software from Biodevices, S. A.  
(A) 
(B) 
Figure 4.4.15 - (A) Variation of the temperature during a sleep recording using VitalSleep prototype and (B) 
sleep staging based on that variation. 
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After that, and based on a study made by Hayano et al., [108] it was necessary to extract 
the values on the x, y and z axis as well as the time when these values occurred. The magnitude 
of the movement was calculated through the root of the values on the x, y, and z axis squared. 
At each 3 minutes the difference between maximum value and minimum value was calculated, 
then all differences that were greater than 1 were considered wake time, since this phase is 
characterized by more movement. [108] In Figure 4.4.16 it is represented the workflow of the 
algorithm developed for wake/sleep staging based on actigraphy data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 4.4.17 (A) it is possible to observe the variation of the magnitude of body move-
ments and (B) the wake/sleep staging based on that variation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.16 – Workflow of the developed algorithm for wake/sleep staging based on actigraphy data 
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Analyzing the Figure 4.4.17 it is possible to verify that wake time corresponds to a higher 
movement. However, it is not possible to know if wake/sleep staging is correct, since PhysioNet 
Database does not provide this type of signal. An alternative to this evaluation would be to 
compare the accelerometer data while sleeping, in a resting position, during a walking and 
during a running. In this way, it would be possible to compare variations of body movements. 
 
In the following section will be shown the result of sleep staging using the VitalSleep pro-
totype for the sleep recording based on the combination on the 4 variables – ECG, EOG, tem-
perature and actigraphy. 
 
4.5. VitalSleep Prototype: Sleep Recording  
 
For sleep staging using the VitalSleep prototype - it is first necessary to place the electrodes 
for EOG and ECG monitoring - Figure 4.5.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) 
(B) 
Figure 4.4.17 - (A) Variation of the magnitude of body movements and (B) wake/sleep staging based 
on that variation. 
Figure 4.5.1 - Placement of EOG electrodes and ECG electrodes. REF – Reference EOG electrode, EOG1 
and EOG2 – EOG electrodes, RA – Right Arm, LA – Left Arm, RL – Right Leg. 
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The acquisition of the sleep recording was made for 200 minutes, under normal conditions 
of temperature. The monitored subject does not have sleep disorders and was awaked when 
the alarm clocked, at the minute 195.  
The prototype has the possibility of incorporating an SD card. The monitoring can be viewed 
in real time by sending data via Bluetooth to the ECG tool, a software from Biodevices S. A. 
Data can be recorded and viewed later through VJ Holter 2, a software also from Biodevices S. 
A. This data is finally extracted and analyzed in MATLAB. In Figure 4.5.2 it is possible to observe 
the signals recorded during this monitorization.  
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Figure 4.5.2 – Signals recorded during sleep using VitalSleep prototype. (A) ECG signal, (B) segment of ECG 
signal, (C) EOG signal, (D) segment of EOG signal, (E) temperature signal and (F) actigraphy signal.  
(F) 
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For the sleeping stage it was developed an algorithm based on the algorithms already de-
veloped – the algorithm that combines the ECG and the EOG variables, the algorithm based on 
the actigraphy signal and the algorithm based on the temperature variations. In Figure 4.5.3 it 
is possible to observe the workflow used to design the algorithm.  
So, first it was used the algorithm based on the combination of ECG and EOG variables to 
stage the sleep in Wake, REM sleep, light sleep and deep sleep. Since both algorithms based on 
the temperature variations and actigraphy data only can differentiate sleep and wake time, if 
the segments that were classified in light sleep (using the combination algorithm between ECG 
and EOG variables) corresponds to a wake time in the algorithm based on the temperature or 
based on the actigraphy, then the segment was reclassified as wake.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Figure 4.5.4 it is possible to observe the sleep staging based on the developed algorithm. 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.3 – Developed sleep staging algorithm based on the 4 signals: ECG, EOG, temperature 
and actigraphy. 
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Although it is not possible to rigorously compare these results with the results of a known 
correct sleep staging, it is possible to analyze the results in a more general way, comparing 
them with an Exam provide by PhisioNet Database - Figure 4.5.5.  
 
This comparation is possible due to the fact that both exams were recorded from subjects 
without sleep disorders and despite variations in the sequences of a hypnogram, it is possible 
to describe a normal night's sleep: N1 phase occurs (light sleep) in the first moment of sleep, 
then the sleep becomes deeper and deeper, passing through phase N2 (light sleep) to phase N3 
(deep sleep). The first episode of deep sleep is long, between 20 to 60 minutes. Then, sleep 
progresses to a lighter sleep state (phases N2 and N1) and may occurs a transient wakefulness 
period before the first REM stage, which appears about 90 minutes after the onset, and lasts 
between 1 and 5 minutes. Thus, ends the first cycle of sleep. It should be noted that the REM 
phase increase throughout the night, contrary to deep sleep. In addition, the periods of vigi-
lance of short duration are very frequent at the end of the night [9]. 
Taking into account the variation of sleep during a normal night's sleep, and comparing the 
sleeping recording using VitalSleep prototype and the Exam provide by PhysioNet Database, it 
is possible to verify that, despite the first phase after the wake time, is the deep sleep when 
it should be light sleep, the first REM phase occurs about 90 minutes after sleep onset and lasts 
Figure 4.5.4 - Sleep staging based on the developed algorithm. 
Figure 4.5.5 – Exam of a subject without sleep disorders provided by PhysioNet Database. 
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about 10 minutes, and the second REM phase has a longer duration. In addition, before REM 
phases it is possible to see a progression from deep sleep to lighter sleep. The short-term waking 
periods at the end of sleep are also characteristic in a normal hypnogram. 
Although it is not possible to rigorously evaluate the accuracy of results, similarities to a 
standard night sleep hypnogram are observed. However, it is necessary to use more data to 
evaluate the results, since only one exam is not enough, it is necessary to monitoring the sleep 
using VitalSleep prototype for different persons and with a medical label. The lack of time to 
do more exams was due to the time dispending in the development of the hardware and signal 
processing. 
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Chapter 5 
 
Conclusions and Future Work 
 
 
 
 
 
Sleep has a major importance in the mental and physical recovery of the body. However, 
sleep disorders are often underestimated.  
Wearable devices appear as an alternative to the standard exam to monitor sleep – poly-
somnography. These devices can perform a continuously monitoring of physiological parame-
ters, at user’s home, without the need of a specialist and are less expensive.  
This Master Thesis showed that although there are some commercial devices that allow 
ambulatory sleep monitoring, is an area that still must grow. The objective of this dissertation 
was to contribute on this field of studies, by developing a prototype of a wearable system for 
sleep monitoring – VitalSleep - that could measure electrooculogram, oxygen saturation, elec-
trocardiogram, temperature and body movements. These last three already acquired by Vi-
talJacket®. The prototype hardware was developed with all variables mentioned above, except 
with the oxygen saturation due to hardware problems and lack of time. Efforts were posteriorly 
made to make possible the incorporation of the oxygen saturation sensor, namely, to have the 
values of the TX root and RX root of the AFE4400 power supply inside the range of expected 
values of the power management circuit. The implementation of the oxygen saturation sensor 
in the forehead and in the ear should further be tested considering that the use of this sensor 
in the forehead may be more comfortable to the user due to the presence of less cable appa-
ratus. Furthermore, as mentioned in the subsection “4.2.6 Wearable Prototype Assembly” some 
problems in the acquisition of the EOG signal are probably due to the unstable incorporation of 
the cables to the PCB therefore it is important to improve the incorporation of EOG electrode 
cables. Considering these alterations, the next steps for the improvement of the hardware are 
the production, assembly, test and validation of the new developed board prototype. 
The development of the VitalSleep prototype was not only focused on the hardware but 
also in the analysis of the signals acquired and the development and evaluation of the sleeping 
stage algorithms. Regarding this latter, it was used simple methods to monitor the sleep, alt-
hough it would be interesting to analyse other characteristics of the EOG signal, such as the 
time curvature of the REM and SEM waves, and the differences of the LF and HF component 
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during the last cycles of one night of sleep. Additionally, for the algorithm based on the ECG 
and EOG variables it is necessary to evaluate them using more data, since the PhysioNet Data-
base only provide two exams without any sleep disorders. For the algorithms based on the 
temperature and on the actigraphy data, it is necessary to evaluate them with a specialist. 
Finally, it is also necessary to acquire more sleep recordings of different people using the 
VitalSleep prototype and evaluate the sleeping stage algorithm with a sleeping stage made by 
a specialist.  
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